PRRN14A
PRELIMINARY
PROXY STATEMENT SUBJECT TO COMPLETION, DATED
APRIL 20, 2009
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A
INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Filed by the
Registrant o
Filed by a Party other than the
Registrant þ
Check the appropriate
box: o
|
|
|
þ
|
|
Preliminary Proxy Statement
|
o
|
|
Confidential, For Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
|
o
|
|
Definitive Proxy Statement
|
o
|
|
Definitive Additional Materials
|
o
|
|
Soliciting Materials Pursuant to
Section 240.14a-12
|
IPC HOLDINGS, LTD.
(Name of Registrant as Specified
in its Charter)
VALIDUS HOLDINGS, LTD.
VALIDUS LTD.
(Name of Person(s) Filing Proxy
Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ No
fee required.
|
|
o |
Fee computed on table below per Exchange Act
Rules 14a-6(i)(1)
and 0-11
|
|
|
|
|
1.)
|
Title of each class of securities to which the transaction
applies:
|
|
|
|
|
2.)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
3.)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act
Rule 0-11
(set forth the amount on which the filing fee is calculated and
state how it was determined):
|
|
|
|
|
4.)
|
Proposed maximum aggregate value of transaction:
|
o Fee
paid previously with preliminary materials
|
|
o |
Check box if any part of the fee is offset as provided by
Exchange Act
Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
|
|
|
1.)
|
Amount Previously Paid:
|
|
|
|
|
2.)
|
Form, Schedule or Registration Statement No.:
|
TABLE OF CONTENTS
PRELIMINARY
COPY SUBJECT TO COMPLETION, DATED
APRIL 20, 2009
GENERAL
MEETING OF THE SHAREHOLDERS
OF
IPC HOLDINGS, LTD.
TO BE HELD
ON ,
2009
PROXY
STATEMENT
OF
VALIDUS HOLDINGS, LTD.
AND VALIDUS LTD.
SOLICITATION
OF PROXIES IN OPPOSITION TO THE PROPOSED AMALGAMATION OF IPC
HOLDINGS, LTD. AND MAX CAPITAL GROUP LTD.
This Proxy Statement (the Proxy Statement) and the
enclosed GOLD proxy card are furnished by Validus Holdings,
Ltd., a Bermuda exempted company (Validus), and
Validus Ltd., a Bermuda exempted company and a wholly-owned
subsidiary of Validus (Validus Ltd.) (for
convenience purposes, throughout this Proxy Statement, we
sometimes refer to Validus as the party soliciting proxies in
connection herewith), in connection with Validus
solicitation of proxies to be used at the annual general meeting
(the Annual General Meeting) of shareholders of IPC
Holdings, Ltd., a Bermuda exempted company (IPC or
the Company), to be held
on ,
2009,
at at
Atlantic Time, and at any adjournments, postponements or
reschedulings thereof. Pursuant to this Proxy Statement, Validus
is soliciting proxies from holders of common shares, par value
$0.01 per share (the Shares), of the Company, to
vote AGAINST the proposal to issue Company Shares in
connection with the Agreement and Plan of Amalgamation, dated as
of March 1, 2009, as amended by Amendment No. 1 to the
Agreement and Plan of Amalgamation dated as of March 5,
2009, among Max Capital Group Ltd. (Max), the
Company and IPC Limited (as the same may be amended, the
Max Amalgamation Agreement) which would result in
the amalgamation of Max with and into IPC Limited, a
wholly-owned subsidiary of IPC that was formed for the purpose
of the amalgamation, with the amalgamated company remaining a
wholly-owned subsidiary of IPC and the name of IPC being changed
to Max Capital Group Ltd. (the Proposed Max
Amalgamation). The specific proposal we are soliciting
proxies to vote AGAINST is proposal #8
(Proposal #8) in the Joint Proxy
Statement/Prospectus included in the Registration Statement on
Form S-4
filed by IPC with the SEC on March 27, 2009, and amended by
Amendment No. 1 to the Registration Statement on
Form S-4 filed on April 13, 2009 (the IPC/Max
S-4).
With respect to the remaining proposals we will vote your Shares
as instructed by you, or if you fail to instruct us, as
indicated in this proxy statement. The Company has
set ,
2009 as the record date for determining those shareholders who
will be entitled to vote at the Annual General Meeting (the
Record Date). The registered offices of the Company
are located at American International Building, 29 Richmond
Road, Pembroke HM 08, Bermuda.
This Proxy Statement and the enclosed GOLD proxy card are first
being mailed to the Companys shareholders on or about
April , 2009.
WE ARE DISTRIBUTING THIS PROXY STATEMENT IN ORDER TO URGE THE
COMPANYS SHAREHOLDERS TO VOTE AGAINST THE
PROPOSED MAX AMALGAMATION. WE BELIEVE THAT THE CONSIDERATION TO
BE PAID TO THE COMPANYS SHAREHOLDERS BY MAX IN THE
PROPOSED MAX AMALGAMATION IS INADEQUATE, AND BETTER ALTERNATIVES
EXIST.
On March 31, 2009, Validus publicly announced that it had
delivered a binding offer to the Company presenting a proposal
(the Validus Offer) to the Company for the
amalgamation of Validus and IPC in an exchange of shares whereby
each IPC common share will be exchanged for 1.2037 Validus
common shares, par value $0.175 per share (the Validus
Shares). The Company announced on April 7, 2009 that
its board of directors (the Companys Board)
determined that the Validus Offer does not constitute a
superior proposal under the terms of the Max
Amalgamation Agreement and reaffirmed its support of the
Proposed Max Amalgamation. As of March 31, 2009 (based upon
closing market prices as of March 30, 2009), the Validus
Offer had a value of $29.98 per Share, or approximately
$1.68 billion in the aggregate, which represented an 18%
premium to the trading value of the Shares as of the market
close on the day prior to the announcement, and a 24% premium
over $24.26, which was the average closing price of the Shares
between March 2, 2009, the day the Company and Max
announced the
Proposed Max Amalgamation, and March 30, 2009, the last
trading day before we announced the Validus Offer. The premium
represented by the Validus Offer may be larger or smaller
depending on the market price of each of the Shares and the
Validus Shares at the effective time of the amalgamation and
will fluctuate between now and then depending on the market
prices upon consummation.
WE ARE NOT ASKING YOU TO VOTE ON OR APPROVE THE VALIDUS OFFER
AT THIS TIME. HOWEVER, A VOTE
AGAINST THE ISSUANCE OF SHARES IN CONNECTION WITH
THE PROPOSED MAX AMALGAMATION WILL SEND A CLEAR MESSAGE TO THE
COMPANYS BOARD THAT IT SHOULD GIVE PROPER CONSIDERATION TO
ALL PROPOSALS WHICH IT RECEIVES, INCLUDING THE VALIDUS
OFFER.
EVEN IF YOU HAVE ALREADY SENT A PROXY CARD TO THE COMPANY, YOU
HAVE EVERY RIGHT TO CHANGE YOUR VOTE. ONLY YOUR LATEST-DATED
PROXY COUNTS. VOTE AGAINST THE PROPOSED MAX
AMALGAMATION BY VOTING AGAINST PROPOSAL #8,
SIGNING, DATING AND RETURNING THE ENCLOSED GOLD PROXY CARD IN
THE POSTAGE-PAID ENVELOPE PROVIDED. NO POSTAGE IS NECESSARY IF
YOUR PROXY CARD IS MAILED IN THE UNITED STATES. THEREFORE, WE
URGE YOU TO SIGN, DATE AND RETURN THE ENCLOSED GOLD PROXY CARD
TO US.
REASONS
TO VOTE AGAINST THE PROPOSED MAX
AMALGAMATION
Validus is soliciting proxies from the Companys
shareholders in opposition to the Proposed Max Amalgamation and
specifically AGAINST the proposal to issue the
Company Shares in connection with the Max Amalgamation
Agreement. Validus urges all of the Companys shareholders
to vote AGAINST the Proposed Max Amalgamation for
the following reasons:
|
|
|
A vote AGAINST the Proposed Max Amalgamation
preserves your opportunity to receive the significant premium
for your Shares contemplated by the Validus Offer which, if
consummated, provides significantly greater financial value than
the Proposed Max Amalgamation.
|
The Proposed Max Amalgamation contemplates providing little or
no premium to the Companys shareholders, who would
continue to hold IPC common shares after the transaction. Based
upon closing prices as of March 30, 2009, the last trading
day prior to its announcement, the Validus Offer had a value of
$29.98 per Share, or approximately $1.68 billion in the
aggregate, which represented an 18% premium to the trading value
of the Shares as of such date and a 24% premium over $24.26,
which was the average closing price of the Shares between
March 2, 2009, the day the Company and Max announced the
Proposed Max Amalgamation, and March 30, 2009, the last
trading day before we announced the Validus Offer. The premium
represented by the Validus Offer may be larger or smaller
depending on the market price of each of the Shares and the
Validus Shares at the effective time of the amalgamation and
will fluctuate between now and then depending on the market
prices upon consummation. Based upon the closing prices on
April 17, 2009, the last practicable date prior to the
filing of this Proxy Statement, the Validus Offer had a value of
$28.77 per Share, or $1.6 billion in the aggregate, which
represented a 7.1% premium to the closing price of the Shares as
of such date and a premium of 13.2% over the March 30, 2009
closing price of the Shares.
We are confident that the Companys shareholders recognize
that the Validus Offer is superior to the Proposed Max
Amalgamation. Information with respect to the range of closing
prices for the Shares for certain dates and periods is set forth
in the IPC/Max
S-4. Validus
urges shareholders to obtain a current market quotation for the
Shares.
|
|
|
A vote AGAINST the Proposed Max Amalgamation
stops the Boards attempt to sell the Company for little or
no premium.
|
The Company has entered into a purported merger of
equals with Max in which the Companys shareholders
will receive little or no premium for their Shares. Although the
Companys Board has stated its belief that the Proposed Max
Amalgamation is a strategic merger of equals, we believe that
its analysis is incorrect and we believe that the Proposed Max
Amalgamation is in fact a sale of the Company. Based upon the
expected roles to be played by the Companys existing
management in the combined company and the proposed name of
Max Capital Group Ltd. for the Company following the
Proposed Max Amalgamation and the retirement and consulting
agreement entered into by the Companys Chief Executive
Officer and President, we believe that the Proposed Max
Amalgamation looks
-2-
much more like an agreement was reached to sell the Company to
Max for little or no premium. In any case, we believe that under
Bermuda law and good governance the Companys Board, in
evaluating any strategic transaction of this type, should
consider available alternative transactions beforehand,
communicate these alternatives clearly to the Companys
shareholders and act to maximize value for the Companys
shareholders, whether on a long-term or short-term basis, and we
believe that the Companys Board has failed to do so in
this case. On February 27, 2009, the trading day
immediately prior to the date that the Proposed Max Amalgamation
was announced, the Proposed Max Amalgamation represented a 1%
premium to the closing price of the Companys Shares (based
on the closing price of Maxs shares on that date
multiplied by the inverse of the 0.6429 exchange ratio in the
Proposed Max Amalgamation). The amount of any premium to be
received by the IPC shareholders, or whether there is any
premium at all will depend on the market prices of the
Companys Shares and the Max common shares at the effective
time of the Proposed Max Amalgamation. Based upon the closing
prices on April 17, 2009, the last practicable date prior
to the filing of this Proxy Statement, the Proposed Max
Amalgamation represented a 0.5% discount to the closing price of
the Companys Shares. You should consider that, since
July 24, 2007 (the date of Validus initial public
offering) through March 30, 2009 (the last trading day
prior to the announcement of the Validus Offer), Maxs
common shares have declined 36.5% whereas the Validus common
shares have appreciated 13.2% over the same period. Although we
believe that the Validus Offer would provide the Companys
shareholders with a significant premium for their Shares,
because both the Proposed Max Amalgamation and the Validus Offer
provide for stock consideration with fixed exchange ratios, the
relative value of each to IPC shareholders will fluctuate based
on changes in the trading prices of Max common shares, Validus
Shares and the Companys Shares.
|
|
|
A vote AGAINST the Proposed Max Amalgamation
rejects a transaction which will materially impair the
Companys balance sheet to the detriment of
shareholders.
|
Under the Proposed Max Amalgamation, the Company will be
assuming the entirety of Maxs assets and liabilities.
Despite statements by the Companys Board of its desire to
reduce earnings volatility through a business combination, it
has chosen a deal in which the Companys shareholders will
assume an investment portfolio with large concentrations of
risky assets, including alternative investments and non-agency
asset-backed securities, and inadequate property and casualty
and life and annuity reserves. According to Maxs most
recent
Form 10-K,
as of December 31, 2008, its holdings of alternative
investments and non-agency asset-backed securities totaled 99%
of its tangible equity, indicating a significant amount of
embedded risk. Also, according to the IPC/Max
S-4, the
Company will have to add $130 million to Maxs
property and casualty and life and annuity reserves, indicating
prior under-reserving.
In contrast, the Validus Offer brings with it no exposure to
alternative investments. Validus investment policy
specifically precludes it from making investments in the
alternative asset class, which we view as having excessive risk
for our policyholders and shareholders.
|
|
|
A vote AGAINST the Proposed Max Amalgamation
rejects a transaction in which it will combine with an
unprofitable company in the guise of
diversification.
|
Under the Proposed Max Amalgamation, the Companys Board
has chosen to combine with an entity that suffered a
comprehensive net loss of $200.4 million, or $3.10 per Max
diluted share, in 2008. Maxs U.S. Specialty segment,
the centerpiece of its diversified businesses,
operated in 2008 with a combined ratio of 138.5%. The combined
ratio is a commonly used measure of an insurance companys
underwriting profitability. It is calculated as the sum of an
insurers net loss ratio and its expense ratio. A combined
ratio below 100% indicates profitable underwriting; a combined
ratio of 100% or higher indicates that premiums are less than
aggregate claims and expenses. The net loss ratio is calculated
by dividing losses and loss expenses incurred (including
estimates for incurred but not reported losses) by net premiums
earned. The expense ratio is calculated by dividing acquisition
costs combined with general and administrative expenses by net
premiums earned. As evidenced by Maxs combined ratio in
2008, Maxs underwriting business was loss-making in 2008.
The Boards choice to combine with a loss-making entity
diversifies the Company and its shareholders into
businesses which have earned returns below what IPC earned on a
standalone basis in the same period. In that context, we would
urge you to consider that Validus earned $45.3 million, or
$0.61 per Validus diluted share, in 2008.
|
|
|
A vote AGAINST the Proposed Max Amalgamation
rejects a transaction which favors the Maxs senior
management over the Companys shareholders.
|
-3-
Although the Companys shareholders will receive little or
no premium in the Proposed Max Amalgamation, the IPC/Max
S-4
discloses that the senior executives of Max will receive
accelerated vesting in 50% of their outstanding unvested equity
awards, even though they will be taking over senior management
positions of the Company after the Proposed Max Amalgamation.
Given that the Proposed Max Amalgamation is a so-called
merger of equals, why are Maxs senior
executives being compensated when you, as the Companys
shareholders, are not? We urge you to carefully read the section
of the IPC/Max
S-4 titled
The Merger Interests of Max Directors and
Executive Officers in the Amalgamation for the details on
these arrangements.
|
|
|
A vote AGAINST the Proposed Max Amalgamation
encourages the Board to consider other alternatives for the
Company.
|
The Section entitled The Amalgamation
Background of the Amalgamation in the IPC/Max
S-4
discloses that the Company contacted a selected list of
third parties who had been identified as potential
counterparties for a business combination prior to
entering into the Max Amalgamation Agreement. However, even
though the Companys Board apparently decided to put the
Company up for sale, it chose a deal with little or no premium
and then justified its decision by labeling the Proposed Max
Amalgamation as a merger of equals. Additionally,
the Company and its advisors specifically excluded parties
(including Validus) from its sale process who might have been
extremely interested in pursuing a business combination. The
Validus Offer is evidence that a premium would have been, and
is, available for the Companys shareholders. The
Companys Board announced on April 7, 2009 that the
Validus Offer does not constitute a superior proposal under the
terms of the Max Amalgamation Agreement and IPC is not permitted
to engage in negotiations or discussions with us or any other
potential bidder under the terms of the Max Amalgamation
Agreement. If the Proposed Max Amalgamation is rejected, the
Companys Board will be encouraged to revisit its duty to
find the best alternative for shareholders and we hope that it
would choose to enter into discussions with Validus or other
potential counterparties.
|
|
|
A vote AGAINST the Proposed Max Amalgamation
clears the way for acceptance of the Validus Offer.
|
Even though the Companys Board has made a determination
against our offer, we believe that the Validus Offer constitutes
a superior proposal to the Proposed Max Amalgamation. When our
proposal was announced on March 31, 2009, the closing price
of the Companys Shares increased by $1.63 (to $27.04 per
share), or 6.4%, over its $25.41 per share closing price on
March 30, 2009. Based upon trading prices of Maxs
common shares, the Proposed Max Amalgamation had a value to the
Companys shareholders of $26.38 per share after market
close on March 30, 2009.
In addition, the Validus Offer provides a number of significant
benefits for the Company and its shareholders, including:
(i) quality diversification into profitable business lines
that create value for the Companys shareholders;
(ii) a strong balance sheet with significantly less
exposure to alternative asset risk, none of which is contributed
by Validus, and lower financial leverage than a combination with
Max; (iii) a larger total GAAP capital base relative to a
combination with Max; (iv) leadership positions in
attractive, profitable business lines such as marine and energy;
(v) low transaction execution risk in the form of no due
diligence requirement and no required approvals from U.S.
insurance regulators; and (vi) a superior outcome for the
Bermuda community and the Companys clients in the form of
a greater commitment to the lines of business underwritten by
the Company.
RETURN YOUR GOLD PROXY CARD AND VOTE AGAINST THE
PROPOSED MAX AMALGAMATION AGREEMENT TODAY.
DO NOT RETURN ANY PROXY CARD THAT YOU RECEIVE FROM THE COMPANY.
EVEN IF YOU HAVE PREVIOUSLY SUBMITTED A PROXY CARD FURNISHED BY
THE COMPANY, IT IS NOT TOO LATE TO CHANGE YOUR VOTE BY SIMPLY
SIGNING, DATING AND RETURNING THE ENCLOSED GOLD PROXY CARD TODAY.
WE URGE YOU TO SEND THE COMPANYS BOARD A CLEAR MESSAGE
THAT A SALE TO MAX FOR LITTLE OR NO PREMIUM IS NOT A DESIRED
OUTCOME AND THAT THEY SHOULD TAKE ALL NECESSARY STEPS TO
CONSIDER ALL OTHER PROPOSALS INCLUDING THE VALIDUS OFFER.
VOTE AGAINST THE PROPOSED MAX AMALGAMATION.
-4-
Important Notice Regarding the Availability of Proxy
Materials for the Shareholder Meeting to be Held
on ,
2009:
The Proxy Statement and our proxy materials are available free
of charge on Validus website at www.validusre.bm.
BACKGROUND
OF THE SOLICITATION
On March 2, 2009, the Company and Max announced that they
had entered into the Max Amalgamation Agreement. The IPC/Max
S-4 provides
a summary of the events leading to Max and the Company entering
into the Max Amalgamation Agreement.
In the morning of March 31, 2009, Edward J. Noonan, the
Chief Executive Officer and Chairman of the Board of Validus,
placed a telephone call to James P. Bryce, the Chief Executive
Officer and President of the Company. Mr. Noonan spoke with
Mr. Bryce and explained that Validus intended to make an
offer to exchange each outstanding IPC common share for 1.2037
Validus common shares, subject to the termination of the Max
Amalgamation Agreement.
Following this telephone call, in the morning of March 31,
2009, Validus delivered a proposal letter containing the Validus
Offer to the Companys Board in care of Mr. Bryce and
issued a press release announcing the Validus Offer. The letter
reads as follows:
March 31,
2009
The Board of Directors of IPC Holdings, Ltd.
c/o James
P. Bryce, President and Chief Executive Officer
American International Bldg.
29 Richmond Road
Pembroke, HM 08
Bermuda
|
|
|
|
Re:
|
Superior Amalgamation Proposal by Validus Holdings, Ltd.
(Validus) to
IPC Holdings, Ltd. (IPC)
|
Dear Sirs:
On behalf of Validus, I am writing to submit a binding offer
pursuant to which Validus and IPC would amalgamate in a
share-for-share exchange valuing IPC shares at an 18.0% premium
to yesterdays closing market price. We believe that an
amalgamation of Validus and IPC would represent a compelling
combination and excellent strategic fit and create superior
value for our respective shareholders.
We unquestionably would have preferred to work cooperatively
with you to complete a negotiated transaction. However, it was
necessary to communicate our binding offer to you by letter
because of the provisions of the Agreement and Plan of
Amalgamation between IPC and Max Capital Group Ltd.
(Max), dated as of March 1, 2009, as amended on
March 5, 2009 (the Max Plan of Amalgamation).
We have reviewed the Max Plan of Amalgamation and see that it
contemplates your receipt of acquisition proposals. Given the
importance of our binding offer to our respective shareholders,
we have decided to make this letter public.
Our binding offer involves a share-for-share exchange valuing
IPC shares at an 18.0% premium to yesterdays closing
market price. Consistent with that, we are prepared to
amalgamate with IPC at a fixed exchange ratio of 1.2037 Validus
shares per IPC share.
Our board of directors has unanimously approved the submission
of our binding offer and delivery of the enclosed signed
amalgamation agreement, so that, upon termination of the Max
Plan of Amalgamation, you will be able to sign the enclosed
agreement with the certainty of an agreed transaction. Our offer
is structured as a tax-free share-for-share transaction and does
not require any external financing. It is not conditioned on due
diligence. The only conditions to our offer are those contained
in the enclosed executed amalgamation agreement.
-5-
Our binding offer is clearly superior to the Max transaction for
your shareholders and is a Superior Proposal as defined in
section 5.5(f) of the Max Plan of Amalgamation for the
reasons set forth below.
Superior Current Value. Our proposed
transaction will provide superior current value for your
shareholders. Our fixed exchange ratio of 1.2037 represents a
value of $29.98 per IPC share, which is a premium of 18.0% to
the closing price of IPCs common shares on March 30,
2009.
Superior Trading
Characteristics. Validus common shares
have superior trading characteristics to those of Max as noted
in the table below.
|
|
|
|
|
|
|
Validus
|
|
Max
|
|
Share Price Change Since Validus IPO(1)
|
|
+13.2%
|
|
−36.5%
|
Mkt. Cap as of 3/30/09
|
|
$2.0 billion
|
|
$0.9 billion
|
Average Daily Trading Volume(2)
|
|
$11.3 million
|
|
$6.7 million
|
Price / Book(3)
|
|
1.05x
|
|
0.76x
|
Price / Tangible Book(3)
|
|
1.13x
|
|
0.77x
|
|
|
|
(1) |
|
Based on the closing prices on March 30, 2009 and
July 24, 2007. |
|
(2) |
|
Three months prior to March 2, 2009, date of announcement
of Max and IPC amalgamation. |
|
(3) |
|
Based on December 31, 2008 GAAP book value per diluted
share and diluted tangible GAAP book value per share using
closing prices on March 30, 2009. |
Less Balance Sheet Risk. The combined
investment portfolio of IPC/Validus is more stable than that of
IPC/Max. Pro forma for the proposed IPC/Max combination,
alternative investments represent 12% of investments
and 29% of shareholders equity. In contrast, Validus does
not invest in alternatives and pro forma for a
Validus/IPC combination, alternative investments
represent 3% of investments and 4% of shareholders equity,
providing greater safety for shareholders and clients.
Superior Long-term Prospects. A
combined Validus and IPC would be a superior company to IPC/Max
with greater growth prospects and synergies with:
|
|
|
|
1.
|
Superior size and scale, with pro forma December 31,
2008 shareholders equity of $3.7 billion and
total GAAP capitalization of $4.1 billion;
|
|
|
2.
|
Superior financial flexibility, with debt/total capitalization
of only 1.8% and total leverage including hybrid securities of
only 9.1%;
|
|
|
3.
|
A global platform, with offices and underwriting facilities in
Bermuda, at Lloyds in London, Dublin, Singapore, New York
and Miami;
|
|
|
4.
|
Superior diversified business mix, with lines of business
concentrated in short-tail lines where pricing momentum is
strongest; and
|
|
|
5.
|
An experienced, proven and stable management team with
substantial expertise operating in IPCs core lines of
business.
|
Our superior growth prospects are evidenced by our historical
track record. Between December 31, 2005 and
December 31, 2008, Validus grew its book value per share
(including accumulated dividends) at a 13.2% compound annual
rate vs. Maxs 8.8% growth over the same period. In 2008,
we grew our book value per share (including accumulated
dividends) by 2.4% vs. Maxs 10.8% decline over the same
period.
Expedited Closing Process. We will be
able to close an amalgamation with IPC more quickly than Max
because we will not require the approval of U.S. insurance
regulators.1
1 To
clarify, as of the date of this proxy statement, the Validus
amalgamation with IPC will not require the approval of
U.S. insurance regulators because neither IPC nor Validus
operates a
U.S.-regulated
insurance business that would require any such approval.
-6-
Substantially the Same Contractual Terms and
Conditions. Our proposed amalgamation
agreement contains substantially the same terms and conditions
as those in the Max Plan of Amalgamation, and for your
convenience we have included a markup of our amalgamation
agreement against the Max Plan of Amalgamation.
Superior Outcome for Bermuda
Community. The combination of Validus and IPC
creates a larger, stronger entity than a combination of Max and
IPC which will benefit the Bermuda community.
Superior Outcome for IPC
Clients. Validus has a greater commitment to
the lines of business underwritten by IPC and has superior
technical expertise and capacity to provide IPC customers with
continuing reinsurance coverage. Max has consistently stated its
intention to reduce its commitment to IPCs business.
Therefore, a combination with Validus will be less disruptive to
IPCs client base.
Our binding offer is clearly a Superior Proposal, within the
meaning of the Max Plan of Amalgamation. We and our financial
advisors, Greenhill & Co., LLC, and our legal
advisors, Cahill Gordon & Reindel LLP, are prepared to
move forward immediately. We believe that our offer presents a
compelling opportunity for both our companies and our respective
shareholders, and look forward to your prompt response. We
respectfully request that the Board of IPC reach a determination
by 5:00 p.m., Bermuda time, on Wednesday, April 15,
2009, that (i) our binding offer constitutes a Superior
Proposal, (ii) it is withdrawing its recommendation for the
transaction contemplated by the Max Plan of Amalgamation and
(iii) it is making a recommendation for the transaction
contemplated by this binding offer.
We reserve the right to withdraw this offer if the Board of IPC
has not reached a determination (i) that our binding offer
constitutes a Superior Proposal, (ii) to withdraw its
recommendation for the transaction contemplated by the Max Plan
of Amalgamation and (iii) to make a recommendation for the
transaction contemplated by this binding offer by
5:00 p.m., Bermuda time, on Wednesday, April 15, 2009.
We further reserve the right to withdraw this binding offer if
you subsequently withdraw your recommendation in favor of our
offer or if you do not sign the enclosed amalgamation agreement
within two business days after the termination of the Max Plan
of Amalgamation.
We look forward to your prompt response.
Sincerely,
Edward J. Noonan
Chairman and Chief Executive Officer
|
|
cc: |
Robert F. Greenhill
Greenhill & Co., LLC
|
John J. Schuster
Cahill Gordon & Reindel LLP
In the afternoon on March 31, 2009, the Company issued a
press release acknowledging receipt of the letter from Validus
outlining the Validus Offer and indicating that the
Companys Board of Directors would review the terms of the
Validus Offer in a manner consistent with its obligations under
the Max Amalgamation Agreement and applicable Bermuda law.
Also in the afternoon on March 31, 2009, Max issued a press
release announcing that it had received from the Company a copy
of the letter from Validus outlining the Validus Offer.
In the morning on April 2, 2009, Max sent a letter to the
Companys Board of Directors purporting to outline the
relative advantages of the pending IPC/Max amalgamation as well
as the business and financial issues raised by the Validus Offer
and issued a press release announcing the letter. The text of
the letter reads as follows:
-7-
Dear Members of the Board:
We are writing regarding the many business and financial issues
raised by the public proposal by Validus Holdings Ltd.
(Validus) to acquire IPC Holdings, Ltd.
(IPC) in lieu of the pending IPC amalgamation with
Max Capital Group Ltd. (Max). The IPC/Max
amalgamation was founded on a shared vision of allowing our
combined group of shareholders to enjoy the benefits of a
strong, diversified operating platform with a proven track
record. The Validus proposal does not offer that.
Rather, in light of the Validus proposal, the IPC Board faces
two starkly contrasting choices:
A. You can agree to be taken over by Validus at a price
that is below IPCs book value. The result of this takeover
for your shareholders would be a minority equity stake in an
entity that offers substantially similar product lines to those
offered by IPC today, with little risk diversification, and
apparently no ability by the IPC Board to steward the longer
term prospects of the company.
OR
B. You can complete the planned merger of equals with Max
at a price that is below Maxs book value. We believe that
this transaction will create a more stable entity that will
provide significant product, geographic and risk diversification
and over which IPCs Board will continue to have
significant influence, which in turn will provide superior
shareholder value.
For the reasons set forth below, and in the accompanying
exhibits, we do not agree with Validus that its proposal
represents a Superior Proposal or is a proposal that
can reasonably be expected to lead to a Superior Proposal
pursuant to the IPC/Max Plan of Amalgamation dated March 1,
2009 (the IPC/Max Plan).
1. A combination with Max delivers 29% more tangible
book value per share to IPC. As we operate in an industry
where the primary valuation driver is a multiple of book value
(and tangible book value), we believe that a transaction that
maximizes the book value to shareholders provides the best
opportunity to generate shareholder value. The IPC combination
with Max is a truly superior proposal versus the takeover
proposal by Validus. The takeover proposal by Validus would
result in IPC receiving only $28.35 in diluted book value per
IPC share and $26.19 of diluted tangible book value per IPC
share from Validus. In contrast, our combination delivers $34.93
of diluted book value per IPC share (a 23.2% premium to Validus)
and $33.83 of diluted tangible book value per IPC share from Max
(a 29.2% premium to Validus). A combination with Max provides
greater underlying value to IPCs shareholders, which we
believe will result in greater upside for both IPC and Max
shareholders.
2. The IPC/Max Plan creates significant value for IPC
shareholders. As we indicated during our discussions, we
believe that the IPC/Max Plan provides an attractive financial
outcome for IPC. The IPC/Max Plan is expected to be accretive to
both earnings per share and return on equity. In addition, as
you consider the historical trading multiples of Max and IPC,
there is significant opportunity to create substantial value for
all shareholders of the combined company. We believe the Validus
proposal prioritizes an immediate premium in the
form of stock for IPC shareholders, while compromising a value
creation opportunity for IPC shareholders. Importantly, the
written proposal by Validus does not contemplate any
participation by the IPC board of directors, whose participation
remains an important consideration for Max in the amalgamation
and provides continuity to shareholders and clients.
3. Max is a truly diversified underwriting platform.
The IPC/Max Plan offers IPCs shareholders superior
current and future value by combining IPC with a truly
diversified underwriting platform, with a strong and well
established track record. Max enjoys a diversified portfolio of
business across many dimensions by class, geography,
customers and distribution. We believe that Maxs
diversified underwriting platform, with its strong emphasis on
profitable longer-tail casualty business, will generate more
stable returns on capital through underwriting cycles, compared
to the volatility embedded in the Validus short-tail portfolio.
Validus, whose 2008 gross premiums written are 94%
concentrated in short- tail lines of business, claims that its
portfolio represents diversification. Validus
ability to deliver anything approaching true diversification
seems to be constrained by its limited underwriting platforms in
Bermuda and at Lloyds and lack of underwriting
capabilities in longer-tail casualty classes.
-8-
Combining two short-tailed property catastrophe companies as
proposed by Validus does little for shareholder diversification.
Validus stated intention to take advantage of currently
strong rates in the property market is a short-term strategy
that is capital intensive, creates greater volatility for
shareholders, and is one which IPC could have continued on a
stand-alone basis but elected not to do so. By contrast, Max
remains committed to an underwriting strategy that produces
attractive results across market cycles, by continuing to expand
its specialty insurance business in selected underwriting
classes and limiting volatility in its underwriting results.
4. Max has a proven, long-term, operating history.
Maxs underwriting has been tested through the tragic
events of 9/11, the active 2004 hurricane season and the
confluence of Hurricanes Katrina, Rita, and Wilma in 2005.
Validus operating history, by contrast, does not extend
beyond the past three years, during which time the industry as a
whole has experienced both strong property catastrophe pricing
and limited catastrophe activity. The first test of
Validus portfolio of business and risk management
capabilities since its formation three years ago came in 2008
with Hurricanes Ike and Gustav. In our view, the results speak
for themselves: the net loss reported by Validus for these
events represented 12.4% of its June 30,
2008 shareholders equity, the largest percentage loss
of its broad peer group which averaged 7.2% of
shareholders equity. The loss was almost double the net
loss incurred by IPC, which represented just 6.7% of IPCs
June 30, 2008 shareholders equity. The losses
recorded by Validus included a 42% increase in its initial loss
estimate for Hurricane Ike (from $165 million to
$235 million) during the fourth quarter of 2008. By
comparison, Maxs net incurred losses from Hurricanes Ike
and Gustav were limited to 3.4% of June 30,
2008 shareholders equity, the lowest among the
broader peer group, demonstrating the lower embedded volatility
of Maxs underwriting results versus Validus.
5. IPC and Max can complete an amalgamation more
quickly, and with greater certainty.
(a) IPC and Max can close our amalgamation
expeditiously. Max believes that the IPC/Max Plan
can close as soon as June 2009. By contrast, we believe that
Validus would not be in a position to close a transaction with
IPC until September 2009 at the earliest, notwithstanding its
public prediction of a second quarter close. As you are well
aware, the IPC/Max Plan requires that shareholders have the
opportunity to vote on our amalgamation before IPCs Board
can terminate our agreement and thereafter begin discussions
with a bidder such as Validus. We anticipate that we will be
able to hold our respective shareholder meetings in June, and
only after those shareholder votes would Validus be able to
pursue its proposal. Validus inability to close before
September 2009, the middle of hurricane season, adds meaningful
uncertainly to Validus proposal, as IPC shareholders and
the transaction itself would be put at risk by the significant
catastrophe exposures of Validus and Validus ability to
terminate the transaction based upon changes in
shareholders equity. Much has been made by Validus
regarding US regulatory approvals required to complete the
IPC/Max amalgamation. As you know, these approvals are well
underway and we do not foresee such requisite approvals
adversely impacting a possible June closing.
(b) IPC has conducted extensive diligence on
Max. IPC was given complete and open access to
Max to afford you and your outside advisors and consultants with
the ability to conduct extensive due diligence on Max. The
Validus proposal seeks to have IPC enter into a transaction for
which IPC has not conducted due diligence. We also note that
certain of Validus disclosure schedules will not be
provided to IPC until after IPC and Maxs shareholders have
the opportunity to vote upon our amalgamation.
6. Maxs business is complementary to IPC.
Clients seek a diversified program of reinsurers. As you
were able to confirm in your due diligence, Max has very limited
overlap with the customers of IPC and neither party expects a
combination of IPC and Max to lead to any meaningful disruption
of either business. In addition, the continuity of the
underwriters at IPC will maximize the opportunity for IPC to
continue to write this business in the future, assuming market
conditions support it. By contrast, Validus acknowledges that it
writes business with many of the same clients as IPC, which we
would expect to result in a loss of business as clients seek to
diversify their reinsurance placements.
7. Maxs complementary and diversified platform is
appreciated by our ratings agencies. Max currently has a
financial strength rating of A- by A.M. Best, with its
outlook changed to positive in December 2008. As IPC and Max
have jointly presented to our ratings agencies, IPCs Board
has the comfort of knowing that the
-9-
ratings agencies view our combination, and its diversifying
impact on IPCs business, positively. In contrast, we
believe that the agencies would not look as favorably on
combining two short-tailed property-oriented platforms.
8. Max maintains less underwriting volatility through
greater diversification of its portfolio of risks. Max seeks
to limit its exposure to catastrophic events (probable maximum
loss based on a 1 in 250 year event) to a maximum of 20% of
its shareholders equity, often operating below this level.
As part of the IPC/Max Plan, we have discussed continuing to
have a significant presence in the property catastrophe market
while on a combined equity basis adhering to this same 20% risk
tolerance. In contrast, Validus maintains peak exposures where
the probable maximum loss based on a 1 in 250 year event
runs at a stated 33% of shareholders equity. Max believes
that combining this risk profile with IPC would expose IPC
shareholders to an even greater level of volatility than at
present and would not change the markets perception of IPC as
being a property catastrophe company. The volatility of
Validus results would also seem to be cause for concern,
particularly when the net losses from Hurricanes Ike and Gustav
(which approximated a 1 in 15 year event) was 12.4% of
shareholders equity, the highest among its broader peer
group. This compared to a net loss of 6.7% of shareholders
equity for IPC and 3.4% for Max.
9. Max has a proven, long-term history of successful
acquisitions without incurring goodwill. We believe
IPCs shareholders can take comfort in Maxs
demonstrated history of successfully entering new business lines
through acquisitions and
start-ups
without incurring meaningful goodwill. For example, when Max
entered the Lloyds market, we booked intangible assets of
$8 million upon closing our acquisition of Imagine Group
(UK) Limited, which stands in contrast to the $154 million
of intangible assets booked by Validus in their acquisition of
Talbot.
10. Max has a diversified shareholder base. We
believe having a shareholder base dominated by five private
equity owners controlling 64.9% of Validus total
beneficial ownership (as of March 13, 2009) will limit
the potential upside in the value of Validus over time as these
private shareholders seek to exit their investment. Max has a
diversified shareholder base with an 84% public float. In
addition, Max has a well diversified shareholder base of high
quality institutional shareholders.
11. IPC and Max have compatible cultures. IPC and
Max have compatible cultures that will help ease the integration
of the two companies. IPC and Max share a common focus on
underwriting, claims and actuarial disciplines, and on running
our respective businesses as meritocracies.
12. Maxs higher asset leverage provides greater
investment income over time. Max believes that investment
leverage (invested assets as a multiple of shareholders
equity) is a positive in driving earnings and stability of
returns on capital over time. Based on 2008 figures, Max had
total investment to equity of 4.2x versus 1.7x for Validus. As
Validus continues to pursue a short-tail strategy, Validus will
be limited in its ability to increase its asset leverage. This
deprives IPC of the meaningful investment income derived from
longer-tail casualty lines and continues to leave IPC
shareholders exposed to increased volatility from catastrophes.
Validus has commented on Maxs investment portfolio,
particularly its alternative investment portfolio. Maxs
year end allocation to alternative investments was 14% of total
invested assets, which is expected to reduce to 10% to 12% in
2009. In looking at results, Maxs total investment return,
including realized and unrealized gains and losses, during the
very volatile period of 2007 / 2008 has outperformed
Validus in 6 of the last 8 quarters.
We believe that the facts regarding the proposal submitted by
Validus and the attempt by Validus to present a one-sided
proposal to IPC shareholders make it clear that Validus has not
presented a Superior Proposal, nor one that can be reasonably
expected to lead to a Superior Proposal. We believe Validus has
created an unnecessary and unproductive disruption for its own
opportunistic purposes, which should not distract either
IPCs or Maxs employees and customers from our
amalgamation, which we both believe to be in the best interests
of our shareholders.
-10-
Lastly, Max remains both steadfast in its commitment and excited
to complete its planned amalgamation with IPC. We continue to
believe that the amalgamation of IPC and Max represents the best
strategic and financial opportunity for our collective
shareholders.
Very truly yours,
W. Marston Becker
Chairman and Chief Executive Officer
Max Capital Group Ltd.
In the afternoon on April 2, 2009, Validus sent a letter to
the Companys Board of Directors addressing the claims made
by Max in its letter to the Companys Board of Directors in
the morning on April 2, 2009. The text of our letter reads
as follows:
April 2,
2009
The Board of Directors of IPC Holdings, Ltd.
c/o James
P. Bryce, President and Chief Executive Officer
American International Bldg.
29 Richmond Road
Pembroke, HM 08
Bermuda
Dear Members of the Board:
We are writing to respond to the letter sent to you by
Mr. Becker of Max Capital Group Ltd. (Max)
dated April 2, 2009, regarding the purported benefits of
the proposed combination of IPC Holdings, Ltd. (IPC)
with Max (pursuant to an Amalgamation Agreement between Max and
IPC dated as of March 2, 2009 (the Amalgamation
Agreement)), as compared to the benefits presented by a
combination of IPC with Validus Holdings, Ltd.
(Validus) on the terms we proposed to you in our
letter dated March 31, 2009 (the Validus
Proposal).
First, we would like to reiterate our sincere belief that the
Validus Proposal is in every respect a Superior Proposal as
defined in the Amalgamation Agreement. In fact, as you have
undoubtedly seen, the markets have already endorsed our
proposal: the IPC share price has increased significantly since
the announcement of our proposal, in recognition of the fact
that our proposal delivers superior value to the IPC
shareholders an irrefutable fact. Our proposal
offers the IPC shareholders superior value (an 18% premium to
the value of the IPC stock on the date prior to our
announcement), a currency with superior trading characteristics
(Validus shares trade at a premium to book value, as opposed to
the Max shares, which trade at a discount to book value), less
balance sheet risk, and most importantly, superior long term
prospects.
Max suggests that the choice you are facing is between
(i) a combined company based on a shared vision in which
you, the IPC Board, can continue your stewardship, and
(ii) an entity which offers you few benefits over what you
have today, with no ability to continue your stewardship. We
view the choice quite differently: you can choose to combine
with a company which, on almost every metric, is a worse choice
for your shareholders, or ours, which delivers, immediately and
in the long term, superior value for your shareholders. To the
extent that you, the members of the IPC Board, have an interest
in continuing involvement in the affairs of the combined
company, we would be happy to discuss continued Board
representation with you.
Turning now to the assertions in the Max letter, we note that
Max has made a number of statements which distort the facts and
present an incomplete picture. We would like to respond to each
of these in turn.
1. A combination with Max delivers 29% more
tangible book value per share to IPC. Max
believes book value per share is a very important measure in our
industry, and we do not disagree. The relevant question
-11-
for the IPC Board, however, is not, as Max suggests, the
relative percentage of book value being delivered to IPC
shareholders in the two proposals, but the absolute value of the
shares themselves. On this measure, the Validus proposal is
clearly superior, as it offers IPC shareholders a significant
premium over the current value of their shares. Moreover, Max
does not explain in its letter why Maxs shares are trading
at such a deep discount to its book value. We can only guess
that the market assigns such a discount because of Maxs
stewardship of its business or because so much of Maxs
investment portfolio is tied up in risky alternative assets.
Indeed, of Maxs $1.2 billion of tangible common
equity, $754 million is in alternative assets, which in
2008 generated mark downs of $233 million, greater than the
entirety of Maxs underwriting income, and
$476 million is in non-agency asset/mortgage backed
securities. We believe it is a far better value proposition for
the IPC shareholders to receive Validus shares, a currency which
the market values at a premium to book.
2. The IPC/Max Plan creates significant value for
IPC shareholders. This statement is simply
incorrect. According to data calculated from the proxy statement
filed by IPC on March 27, 2009, IPCs book value per
share would decrease from $33.00 to $32.30, or 2.1% as a result
of the combination with Max (this obviously implies the deal is
accretive to Max at your expense). That can hardly be described
as the best opportunity to deliver shareholders
value. Moreover, while it is true that the Validus
proposal delivers an immediate premium for IPC shareholders, it
wrong of Max to suggest that such a premium will compromise
value creation for IPC shareholders in the longer term. We
believe that receiving a better currency, in a stronger, better
capitalized company, offers a more likely starting point for
long term value creation than retaining shares in IPC, whose
previously conservatively managed balance sheet will be
negatively impacted by assets of questionable value in the
IPC/Max combination.
3. Max is a truly diversified underwriting
platform. We think the relevant question
for IPC is not whether its merger partner has a diversified
platform, but rather the quality of that diversification. In
terms of the quality of diversification, Validus offers far
superior characteristics than Max, as evidenced by 2008 results
for Maxs diversified businesses. Maxs
2008 reported 91.9% property and casualty GAAP combined ratio
benefited from $107.0 million of prior-year reserve
releases. The true 2008 accident-year GAAP combined ratio was
103.4%. Maxs diversified businesses represent
diversification without profit. Maxs chief source of
diversifying growth, Max US Specialty, generated a 138.5%
combined ratio in 2008. Results such as those cannot create
value for shareholders. Max is not a leader in any category of
business, and moreover, it has chosen to focus on volatile lines
of business which yield low margins. In contrast, Validus is a
global leader in very profitable business lines, including
marine, energy and war and terrorism. Furthermore, Maxs
statement that Validus is constrained by its limited
underwriting platforms is demonstrably untrue. Validus has the
global licenses and other capabilities in place to write long
tail insurance if and when it believes doing so would be
profitable. In fact, today, Validus writes non-catastrophe
business in 143 countries around the world. And, as demonstrated
by Validus superior financial results and lower combined ratio,
Validus does so profitably.
4. Max has a proven, long-term, operating
history. Max may have a longer history than
Validus, but even a cursory look at the decline in Maxs
book value, its weak growth, volatile results and general
underperformance will quash any notion that the length of its
operating history trumps the superior abilities of the deeply
experienced Validus management team to generate best in class
performance.
By focusing on the net loss reported by Validus based on
hurricanes Ike and Gustav, Max is yet again ignoring the larger
benefit of Validus conservative risk management and
diversification. Validus assumed that the hurricane season in
2008 would generate a market loss of $18 to $21 billion,
and we set our reserve levels accordingly. IPC, by contrast,
assumed $14.5 billion of losses. Notwithstanding the
severity of the events of that hurricane season, Validus was
easily able to absorb the loss (yielding a combined ratio of
92.2%, with a corresponding combined ratio at Validus Re of
86.0%). As a result, Validus was profitable, notwithstanding the
losses associated with hurricanes Gustav and Ike. Its highly
touted diversification notwithstanding, Max sustained a loss for
the year in excess of $200 million, demonstrating beyond a
shadow of a doubt that its greater diversification
is not a guarantee of profitability.
We at Validus believe that our diversification is of a higher
quality, our underwriting decisions are made more carefully, our
risks are managed more prudently, and we exercise a more
conservative stewardship over
-12-
our capital, all of which would inure to the long term benefit
of the IPC shareholders in our proposed combination.
5. IPC and Max can complete an amalgamation more
quickly, with greater certainty. Max now
claims (contrary to the statements it made prior to the Validus
Proposal) that Max and IPC will be able to close their
amalgamation in June 2009. Max freely admits, however, that it
does not control the time table: the SEC must clear the proxy
statement/prospectus filed by IPC, it must clear the proxy
statement for Max, and the parties must obtain shareholders
approval (which we believe will be difficult to do while our
Superior Proposal is pending). Most importantly, the closing of
the IPC/Max transaction requires regulatory approvals from
several different state insurance departments in the United
States. Implicit in Maxs prediction of a closing date is a
presumption of the receipt of regulatory approvals, which simply
cannot be taken for granted given the likely timing of
regulatory review and the public hearing process. Thus there is
absolutely no guarantee that the IPC/Max deal can be consummated
in the second quarter. Finally, it is important for the IPC
Board not to lose sight of the fact that the Amalgamation
Agreement cedes to Max the power to delay the closing of a
Validus/IPC
combination.2
Max also tries to make an issue of the fact that IPC has not had
a chance to conduct due diligence on Validus. Validus would
welcome the opportunity to provide IPC with customary due
diligence information. Validus stands ready to respond to any
requests IPC may make on an expedited basis, and would be more
than happy to meet with IPC to answer any questions IPC may have
about Validus, its operations, its financial health or any other
matter relevant to the Board of IPC in considering Validus
Superior Proposal. We call upon Max to permit IPCs Board
to exercise its fiduciary duties by releasing IPC from the
extraordinarily restrictive prohibition in the Amalgamation
Agreement which prevents it from even talking to Validus
regarding the terms of its Superior Proposal.
6. Maxs business is complementary to
IPC. Maxs assertions that a
combination of Validus and IPC would result in a loss of
customers are without merit and are particularly surprising,
given that Max has publicly stated its intention to
significantly reduce IPCs core reinsurance activities. As
we are both aware, the current reinsurance market is in the
midst of a capacity shortage. As a result, we do not believe
that clients will actively seek to diversify their reinsurance
placements away from our combined company. In fact, our combined
financial strength and clout should only serve to make a
combined Validus/IPC a go-to player for reinsurance
placements.
7. Maxs complementary and
diversified platform is appreciated by our ratings
agencies. We have been in dialogue with our
ratings agencies with regard to our proposal. We encourage the
Board of IPC to focus its attention on what the ratings agencies
actually say, rather than on Maxs speculations.
8. Max maintains less underwriting volatility
through greater diversification in its portfolio of
risks. Due to the significant investment
losses Max sustained in 2008, it is unsurprising that Max is
attempting to focus on underwriting volatility alone.
Selectively focusing on underwriting volatility wholly ignores
the other various risks and uncertainties that IPCs
shareholders would be assuming by combining with Max and its
risky balance sheet. With respect to underwriting performance,
in 2008, Validus successfully weathered its exposures from
Hurricanes Ike and Gustav with a combined ratio of 92.2% and net
income of $63.9 million. This performance was generated
despite the fact that Validus reserved for those events more
conservatively than its industry peers, as discussed in
paragraph 4 above. Validus disclosures offer the
highest level of transparency with regard to its probable
maximum losses, zonal aggregates and realistic disaster
scenarios and we would challenge Max to provide the same level
of transparency to its shareholders before presumptuously
speculating on the impacts of various potential events.
9. Max has a proven, long term history of
successful acquisitions without incurring good
will. Validus has a proven track record of
acquiring a high quality premier business with a leading
position in its market. Maxs pointing to its acquisition
of Imagine Group (UK) Limited as an example of a successful
2 To
clarify, as of the date of this proxy statement, the Max
Amalgamation Agreement cedes to Max the power to delay the
closing of a Validus/IPC combination because IPC has no right to
terminate the Max Amalgamation Agreement until after the vote of
the IPC shareholders at the Annual General Meeting, even if the
IPC Board changes its recommendation and recommends a vote
FOR the Validus Offer.
-13-
acquisition is ironic, especially relative to our successful
acquisition of Talbot. In that transaction, Validus acquired a
strong balance sheet with excess reserves at a multiple of 3.1x
earnings demonstrating Validus commitment to creating
value for our shareholders. When we acquired Talbot, Validus
booked $154 million of goodwill and intangible assets;
however, from acquisition closing until December 31, 2008,
we benefited from $105 million in reserve releases from the
Talbot business, emanating from periods prior to the
acquisition. [Sentence omitted.]
10. Max has a diversified shareholder
base. Maxs attempt to characterize
our shareholder base as a liability is baseless. What is
relevant is the relative liquidity of Max and Validus shares. As
previously mentioned in our letter dated March 31, 2009,
Validus daily average trading volume was
$11.3 million vs. $6.7 million for Max for the three
months prior to announcement of the IPC/Max transaction.
Additionally, since our shareholder base is publicly disclosed,
if the market viewed it as an overhang, such
information would already be embedded in the market price of our
common shares. The combination of our trading volume and the
premium pricing of our shares compared to either Max or IPC
should put to rest any concerns IPC shareholders may have
regarding liquidity of the combined company.
11. IPC and Max have compatible
cultures. Max has mentioned that it has a
compatible culture with IPC. If that is in fact the case, we
find the paucity of IPC management that will continue in senior
roles at IPC/Max curious and an indication that such cultural
fit may be only skin deep. We have successfully integrated large
acquisitions in the past, and believe that experience is most
relevant in this regard.
12. Maxs higher asset leverage provides
greater investment income over
time. Maxs asset leverage has been a
significant liability given its risky investment strategy. This
leverage would similarly expose a combined IPC/Max to
significant volatility. Maxs alternative investments and
non-agency asset/mortgage backed securities alone comprise 99%
of its tangible equity, indicating a massive amount of embedded
risk. Maxs $233 million loss in 2008 on their
alternative investment portfolio is entirely indicative of that
risk. Its so-called outperformance in 6 of the last 8
quarters ignores the abject underperformance it
experienced in other periods. In 2007, when the global credit
crisis began, Maxs current management had the opportunity
to liquidate its alternative assets. Max chose to continue
holding those risky investments, which have led to massive
losses. Combined, we believe these factors highlight Maxs
poor history as stewards of shareholder capital.
* * *
In closing, I would like to reiterate that we have submitted to
you a proposal which we are confident the IPC Board will agree
is a Superior Proposal as defined in your
Amalgamation Agreement. We have submitted this proposal because
we deeply and honestly believe that the combination of IPC and
Validus will result in a far better value proposition for the
IPC shareholders than the combination of IPC and Max. Validus is
absolutely committed to our Superior Proposal and we simply do
not understand how Max can characterize our actions as
opportunistic. If Max truly believes its combination
with IPC is superior, we call upon Max to free the IPC Board
from the shackles that your Amalgamation Agreement has placed on
the ability of the members of the IPC Board to exercise their
fiduciary duties under Bermuda law, so as to create a level
playing field on which the shareholders of IPC will be able to
decide which of the two proposals is indeed superior.
Sincerely,
Edward J. Noonan
Chairman and Chief Executive Officer
-14-
In the afternoon on April 5, 2009, Validus sent a letter to
the Companys Board of Directors regarding an error that
Max had made in its calculation of pro forma tangible book value
under the terms of the Validus Offer. The text of our letter
reads as follows:
April 5,
2009
The Board of Directors of IPC Holdings, Ltd.
c/o James
P. Bryce, President and Chief Executive Officer
American International Bldg.
29 Richmond Road
Pembroke, HM 08
Bermuda
Dear Members of the Board:
We are writing to call to your attention an error contained in
the publicly disseminated letter sent to you by Mr. Becker
of Max Capital Group Ltd. (Max) dated April 2,
2009 and the accompanying presentation materials, regarding the
purported benefits of the proposed combination of IPC Holdings,
Ltd. (IPC) with Max (pursuant to an Amalgamation
Agreement between Max and IPC dated as of March 2, 2009
(the Amalgamation Agreement)), as compared to the
benefits presented by a combination of IPC with Validus
Holdings, Ltd. (Validus) on the terms we proposed to
you in our letter dated March 31, 2009 (the Validus
Proposal).
In his letter, Mr. Becker states (and he has been widely
quoted in the media stating) that [a] combination with
Max delivers 29% more tangible book value per share to
IPC. This is not correct. We, and our
financial advisors and SEC counsel, have reviewed this
calculation and we would like to provide you with the correct
figures. Specifically, Mr. Beckers calculation
understates the pro forma IPC share of Validus tangible book
value per share by $2.74, which results in overstating the
premium calculated on this basis quite significantly. We have
attached some materials that illustrate the correct calculation.
Our SEC counsel has advised us that this error is material and
that Max will be required to amend its SEC filings to correct
its error.
As we noted in our letter dated April 2, 2009, putting
aside this error, we believe that this measure is the wrong
framework on which to analyze whether the IPC/Max plan is
superior to the IPC/Validus plan, and refer you to the analysis
in our earlier letter. We remain confident that the IPC Board
will agree the Validus Proposal is a Superior
Proposal as defined in your Amalgamation Agreement.
We look forward to your response to the Validus Proposal.
Sincerely,
Edward J. Noonan
Chairman and Chief Executive Officer
cc: Marty Dolan, J.P. Morgan Securities, Inc.
In the afternoon on April 5, 2009, Validus also posted the
material referenced in the letter on its website.
On the morning of April 6, 2009, Max issued a press release
reaffirming its prior disclosure regarding the Validus Offer and
stating that it continues to believe that Validus had not
presented a Superior Proposal, nor one that can be reasonably
expected to lead to a Superior Proposal (as such term is defined
in the [Max Amalgamation Agreement]).
-15-
In the afternoon on April 6, 2009, Validus sent a letter to
the Companys Board of Directors regarding the Max press
release and issued a press release announcing the letter. The
text of our letter reads as follows:
April 6,
2009
The Board of Directors of IPC Holdings, Ltd.
c/o James
P. Bryce, President and Chief Executive Officer
American International Bldg.
29 Richmond Road
Pembroke, HM 08
Bermuda
Dear Members of the Board:
The difficulty of being unable to speak directly has lead to an
exchange of press releases, which is unfortunate. In this
context, we would like to respond to the Max statement issued
this morning by describing the analytical framework we believe
is appropriate.
In todays press release, Max modified its description of
its calculation of pro forma book value per share. In essence,
the Max calculation now describes what an IPC shareholder would
receive on a standalone basis from either Validus or Max. We
disagree with this basis for valuation. Our approach is focused
on a comparison of what an IPC shareholder would own as a result
of either transaction.
However, if we were to follow the Max approach, we would note
that there are a number of adjustments contemplated in the
proposed IPC/Max Amalgamation Agreement, which would reduce the
standalone value that Max delivers by $117.4 million. The
joint proxy statement/prospectus filed by IPC and Max
references, among other adjustments, the need to increase
Max loss reserves for annuity claims as well as property
and casualty claims by $130.0 million. As a result, the Max
book value delivered would be reduced by $2.06 per Max share,
resulting in a book value delivered of $20.40 per share, on the
basis of Maxs calculation of diluted book value.
I would also note that Validus and Max use differing accounting
conventions for calculating diluted book value per share. While
each is valid, on the basis upon which Validus calculates
diluted book value per share, the Max value delivered would be
$19.68 after a $1.81 per share reduction in book value.
We have provided the attached schedule of our calculations in an
effort to be as transparent as possible in our communication
with you.
Sincerely,
Edward J. Noonan
Chairman and Chief Executive Officer
cc: Marty Dolan, J.P. Morgan Securities, Inc.
-16-
Adjustments
to Max Book Value Upon Combination with IPC
|
|
|
|
|
(In millions, except per share values)
|
|
|
|
|
Net book value of net assets acquired prior to fair value
adjustments(1)
|
|
$
|
1,280.3
|
|
Preliminary adjustments for fair value
|
|
|
|
|
Adjustment to deferred acquisitions costs(2)
|
|
|
(51.3
|
)
|
Adjustment to goodwill and intangible assets(3)
|
|
|
(12.0
|
)
|
Adjustment to reserve for property and casualty losses and loss
adjustment expenses(4)
|
|
|
(60.0
|
)
|
Adjustment to life and annuity benefits(4)
|
|
|
(70.0
|
)
|
Adjustment to unearned property and casualty premiums(5)
|
|
|
51.3
|
|
Adjustment to senior notes(6)
|
|
|
24.6
|
|
|
|
|
|
|
Total adjustments
|
|
|
(117.4
|
)
|
|
|
|
|
|
Fair value of net assets acquired
|
|
$
|
1,162.9
|
|
Total adjustments
|
|
$
|
(117.4
|
)
|
Max diluted shares outstanding(7)
|
|
|
64.9
|
|
|
|
|
|
|
Adjustment per diluted share
|
|
$
|
(1.81
|
)
|
|
|
|
|
|
Source: Note 1 to unaudited pro forma consolidated
financial information of IPC in
Form S-4
filed
3/27/2009
(S-4).
Notes 1-6
are excerpts from the
S-4.
|
|
|
|
(1)
|
Represents historical net book value of Max.
|
|
|
(2)
|
Represents adjustment to reduce the deferred acquisition costs
of Max to their estimated fair value at December 31, 2008.
|
|
|
(3)
|
Represents adjustment to reduce goodwill and intangible assets
of Max to their estimated fair value at December 31, 2008.
|
|
|
(4)
|
The fair value of Maxs reserve for property and casualty
losses and loss adjustment expenses, life and annuity benefits,
and loss and loss adjustment expenses recoverable were estimated
based on the present value of the underlying cash flows of the
loss reserves and recoverables. In determining the fair value
estimate, IPCs management estimated a risk premium deemed
to be reasonable and consistent with expectations in the
marketplace given the nature and the related degree of
uncertainty of such reserves. Such risk premium exceeded the
discount IPCs management would use to determine the
present value of the underlying cash flows.
|
|
|
(5)
|
Represents the estimated fair value of the profit within
Maxs unearned property and casualty premiums. In
determining fair value, IPCs management estimated the
combined ratio associated with Maxs net unearned property
and casualty premiums.
|
|
|
(6)
|
Represents adjustment to record Maxs senior notes to their
estimated fair value at December 31, 2008.
|
|
|
|
|
(7)
|
Common shares outstanding plus the gross amount of all warrants,
options, restricted shares, RSUs, restricted common shares and
performance share units outstanding as of the
12/31/2008
balance sheet date (Source: Max 2008
Form 10-K).
|
-17-
In the afternoon on April 7, 2009, Kenneth L. Hammond,
Chairman of the Companys Board of Directors, sent a letter
to Mr. Noonan indicating that the Companys Board of
Directors had reaffirmed its recommendation to combine with Max.
The text of the letter reads as follows:
April 7,
2009
Edward J. Noonan
Chairman & Chief Executive Officer
Validus Holdings Ltd.
19 Par-La-Ville Road
Hamilton, HM 11
Bermuda
Dear Mr. Noonan:
I am writing to respond to your letter of March 31, 2009,
submitting an offer pursuant to which Validus would combine with
IPC.
IPCs board of directors, after careful consultation with
management and our financial and legal advisors, has unanimously
concluded that the Validus proposal does not constitute a
Superior Proposal as defined in the Agreement and Plan of
Amalgamation with Max Capital Group Ltd. dated March 1,
2009. Furthermore, IPCs board of directors has unanimously
reaffirmed its recommendation that IPC shareholders vote in
favor of the transaction with Max.
In reaching its decision, IPCs board of directors
considered several factors, including the following:
|
|
|
|
|
The Validus Offer Fails to Meet IPCs Diversification
Goals During 2008, IPCs board of directors
concluded that it would be in IPCs best interest to
diversify beyond its monoline property catastrophe business
model in order to reduce the volatility inherent in focusing on
catastrophe reinsurance and to spread our risk base across less
correlated risks. A key factor in our decision to choose Max
over other options is our belief that Maxs diversified
operations offer the best path to achieve this goal. The
decision was the result of a robust and thorough review of
strategic alternatives. A transaction with Validus would not
accomplish that strategic objective given Validuss
substantial correlated catastrophe exposure.
|
|
|
|
The Max Transaction Has Significant Value Creation Potential and
Upside for IPC Shareholders The combination with Max
has the potential to create significant value for IPC
shareholders, as detailed in the filed
S-4
registration statement dated March 27, 2009. It also
provides greater book value per share to IPC shareholders.
Furthermore, Maxs balance sheet has significantly lower
goodwill and intangibles, resulting in an even greater tangible
book value per share to IPCs shareholders. We are
concerned that Validuss proposal enables Validus to raise
capital at a discount to book value at the expense of IPC
shareholders, on the other hand, the combination with Max allows
deployment of capital under a combined business plan that
benefits IPCs shareholders. Maxs diversified book,
when combined with IPCs, has the potential to reduce
earnings volatility. Earnings volatility affects share price
volatility, ratings and other important financial measures. A
combination with Max carries less risk, as this combination is
less exposed to catastrophe events and other risk
concentrations. On the other hand, Validuss earnings and
share price are more affected by catastrophe losses. At the time
of the Validus offer, its share price was near the high end of
its 52-week trading range, resulting in an exchange ratio that
poses potential downside risk to IPC shareholders. In contrast,
we entered into the transaction with Max at an exchange ratio
determined at a time that Max was trading at 53% of its 52-week
high.
|
|
|
|
The Validus Amalgamation Proposal Is Less Certain, Is
Riskier for IPCs Shareholders and Would Take Longer to
Close We currently expect to be able to complete the
transaction with Max in June, with all regulatory approvals
obtained. In contrast, in our view, any transaction with Validus
likely could not be completed before September, right in the
middle of the wind season. Our transaction with Max would have
to be rejected by IPC shareholders before IPC would be able to
conduct due diligence on
|
-18-
|
|
|
|
|
and negotiate with Validus. There is no assurance IPC would, at
that time, choose to enter into a transaction with Validus. Even
if IPC were to proceed with Validus at that time, Validus and
IPC would both need to obtain consents under their credit
facilities before the deal could close, whereas no such
additional consents would be necessary to close the IPC/Max
transaction. Validus and IPC would also need to achieve
satisfactory indications from the ratings agencies regarding the
ratings outcomes of such a combination.
|
Given these considerations and others, the board of directors
unanimously determined that the Validus proposal does not
constitute a Superior Proposal as defined in our amalgamation
agreement with Max. IPC remains committed to completing our
transaction with Max, which we believe will create a diversified
and balanced platform for growth that should drive stronger
performance and value for shareholders for many years.
Sincerely,
Kenneth L. Hammond
Chairman of the Board of Directors
On Behalf of the IPC Holdings Board of Directors
-19-
In the afternoon on April 8, 2009, Validus sent a letter to
Mr. Hammond, the Chairman of the Companys Board of
Directors, regarding the IPC press release and letter and issued
a press release announcing the letter. The text of our letter
reads as follows:
April 8, 2009
Kenneth L. Hammond
Chairman
IPC Holdings, Ltd.
American International Bldg.
29 Richmond Road
Pembroke, HM 08
Bermuda
Dear Mr. Hammond,
I am writing in response to your letter of April 7, 2009,
in which you confirm the continuing support of the IPC board for
the Max takeover of IPCs operations.
I am disappointed with the Boards decision and
respectfully disagree with your assessment of our Superior
Proposal. I am confident that had your Amalgamation Agreement
with Max allowed you to engage in dialogue with us, you would
have instead supported the Validus Superior Proposal on behalf
of your shareholders. In particular, although you cite a
robust and thorough review of strategic
alternatives, I am greatly disappointed that you never invited
us to participate in that process, although you spoke with
numerous potential buyers. To the extent that Max will release
you from the restrictive terms of the Amalgamation Agreement, we
continue to stand ready to discuss your objectives and how our
business meets those objectives. Until you agree to discuss our
proposal with us, we have no choice except to communicate
directly with your shareholders. We believe the facts will
demonstrate that our proposal is truly a Superior Proposal.
We hereby advise the shareholders of IPC that:
1. We have retained Georgeson as our proxy solicitor. We
will shortly file proxy solicitation materials with the SEC and
those materials will contain, among other things, the many
reasons why we believe you should vote against the Max takeover.
Once the proxy is effective, Georgeson will be in touch with
IPCs shareholders to solicit their votes AGAINST the Max
takeover. If, as we
[hope]3,
IPCs shareholders vote down the Max takeover, you will be
unencumbered by the restrictive Amalgamation Agreement and free
to execute the Validus Agreement.
2. In our capacity as an IPC shareholder, we object to the
punitive nature of the $50 million Max Termination Fee. The
Termination Fee is an unenforceable penalty under Bermuda law
and we are commencing litigation to reduce this penalty. If
successful,4
we will permit IPC to pay the amount by which such penalty is
reduced as a dividend to IPC shareholders, so that IPC
shareholders and not Max or Validus
shareholders will share in the value obtained.
3 To
clarify, as of the date of this proxy statement, the word
hope has been inserted to replace the word
expect in this sentence.
4 To
clarify, as of the date of this proxy statement, the reference
to success in this sentence relates to Validus
success in pursuing the litigation strategy referenced in the
immediately prior sentence followed by the successful
consummation of the Validus Offer.
-20-
I regret that the terms of the Max takeover preclude the
management teams of IPC and Validus from cooperating in
delivering a superior outcome for IPC shareholders, but we are
pleased to work directly with your shareholders to achieve the
same end. We remain fully committed to our proposal.
Sincerely,
Edward J. Noonan
Chairman and Chief Executive Officer
On April 9, 2009, Validus filed this preliminary proxy
statement with the SEC with respect to soliciting votes against
the approval of the Proposed Max Amalgamation.
On April 13, 2009, IPC filed Amendment No. 1
(Amendment No. 1) to the IPC/Max S-4, which,
among other things, added to the disclosure regarding the
background to the Proposed Max Amalgamation including the
reasons as to why Validus was excluded from the process that
resulted in the Proposed Max Amalgamation. Amendment No. 1
also contained a correction to IPCs diluted book value for
the year ended December 31, 2008.
On April 16, 2009, Validus filed a preliminary proxy
statement with respect to soliciting votes from Validus
shareholders to approve the issuance of Validus Shares in
connection with the acquisition of all of the outstanding Shares
pursuant to the amalgamation agreement delivered by Validus as
part of the Validus Offer.
On April 20, 2009, Validus filed an amendment to this
preliminary proxy statement with the SEC.
-21-
CERTAIN
INFORMATION CONCERNING THE PROPOSED MAX AMALGAMATION
At the Annual General Meeting, the Companys shareholders
of record at the close of business on the Record Date will be
voting on, among other things, whether to approve the issuance
of Shares in connection with the Proposed Max Amalgamation.
According to the IPC/Max
S-4, under
the terms of the Max Amalgamation Agreement, each outstanding
Max common share (the Max Shares), other than Max
Shares held by Max as treasury shares, will be cancelled and
converted into the right to receive 0.6429 IPC common shares,
par value $0.01 per share (the IPC Shares) (together
with cash in lieu of fractional shares). IPC shareholders would
continue to retain their shares after the Proposed Max
Amalgamation. According to the IPC/Max
S-4, as a
result of the Proposed Max Amalgamation, the Companys
shareholders would end up owning approximately 58% of the
combined company. The conditions to the consummation of the
Proposed Max Amalgamation include the following:
(1) adoption of the Max Amalgamation Agreement and approval
of the Proposed Max Amalgamation by Maxs shareholders,
(2) approval by the Companys shareholders of
(i) the issuance of the Companys shares to
shareholders of Max on the terms and conditions set out in the
Max Amalgamation Agreement and (ii) certain amendments to
the Companys bye-laws, (3) receipt of all regulatory
approvals, (4) absence of any applicable law prohibiting
the Proposed Max Amalgamation, (5) effectiveness of the
registration statement registering the Company common shares to
be issued in the Proposed Max Amalgamation,
(6) authorization of the listing of such Company common
shares on Nasdaq, (7) the truth and correctness of the
representations and warranties of the Company and Max set forth
in the Max Amalgamation Agreement in all material respects,
(8) performance by the Company and Max of their respective
material obligations under the Max Amalgamation Agreement, and
(9) receipt by the Company and Max of opinions of their
respective legal counsel with respect to certain
U.S. federal income tax consequences of the Proposed Max
Amalgamation.
The Max Amalgamation Agreement also provides that the
termination of the Max Amalgamation Agreement by either party
under certain circumstances specified in the Max Amalgamation
Agreement, including the termination by Max if the
Companys Board withdraws or adversely modifies its
approval or recommendation to shareholders of the Proposed Max
Amalgamation, will require the Company to pay Max
$50 million as a termination fee.
The Max Amalgamation Agreement also provides for the payment by
the Company to Max of the $50 million termination fee if
the Max Amalgamation Agreement is terminated in the following
circumstances: (i) by Max if the Companys Board
withdraws, modifies or changes its recommendation of the
Proposed Max Amalgamation in a manner adverse to Max in
reference to a third party acquisition proposal or (ii) by
the Company or Max if (a)(x) the Max Amalgamation Agreement
has not been consummated by November 30, 2009 or
(y) the Companys shareholder approval for the
Proposed Max Amalgamation has not been obtained, (b) prior
to the Annual General Meeting a third party acquisition proposal
has been made or otherwise becomes publicly known or any person
has publicly announced an intention to make a third party
acquisition proposal and (c) within 12 months after
termination of the Max Amalgamation Agreement, the Company or
any of its subsidiaries enters into a contract or agreement with
respect to, or consummates, a third party acquisition proposal
with the person that made such acquisition proposal.
WE ARE DISTRIBUTING THIS PROXY STATEMENT IN ORDER TO URGE THE
COMPANYS SHAREHOLDERS TO VOTE AGAINST THE
PROPOSED MAX AMALGAMATION. WE BELIEVE THAT THE CONSIDERATION TO
BE PAID BY MAX IN THE PROPOSED MAX AMALGAMATION IS INADEQUATE,
AND BETTER ALTERNATIVES EXIST.
CERTAIN
INFORMATION CONCERNING VALIDUS AND VALIDUS LTD.
Validus is a Bermuda exempted company, with its principal
executive offices located at 19 Par-La-Ville Road Hamilton
HM11 Bermuda. The telephone number of Validus is
(441) 278-9000.
Validus is a global provider of short-tail lines of reinsurance,
including property catastrophe, property pro-rata and property
per risk, marine and energy, and other specialty lines. Validus
was formed in Bermuda in December 2005 following the significant
natural catastrophes of 2005 with an experienced management team
and an unencumbered capital base of approximately
$1 billion. Validus shares are traded on the NYSE
under the symbol VR and, as of the date preceding
the filing of this Proxy Statement, Validus had a market
capitalization of approximately $1.84 billion.
-22-
Validus has approximately 280 employees. Validus acquired
100 Shares, through its wholly owned subsidiary, Validus
Reinsurance, Ltd., a Bermuda exempted company, in the open
market on April 8, 2009. As of the date of the filing of
this Proxy Statement with the SEC, Validus beneficially owns
100 Shares, or less than 1% of the outstanding Shares.
Validus Ltd. is a recently formed Bermuda exempted company
organized in connection with the acquisition of the
Companys common shares and the Validus Offer and has not
carried on any activities other than in connection therewith.
The principal offices of Validus Ltd. are located at
19 Par-La-Ville Road Hamilton HM11 Bermuda. The telephone
number of Validus Ltd. is
(441) 278-9000.
Validus Ltd. is a wholly owned subsidiary of Validus.
Unless Validus Ltd. exchanges Shares on behalf of Validus
pursuant to the Validus Offer, it is not anticipated that
Validus Ltd. will have any significant assets or liabilities or
engage in activities other than those incidental to its
formation and capitalization.
Information for each of the directors and executive officers of
Validus and Validus Ltd. who are considered to be participants
in this proxy solicitation and certain other information is set
forth in Schedule I hereto. Other than as set forth herein,
none of Validus, Validus Ltd. or any of the participants set
forth on Schedule I hereto have any interest, direct or
indirect, by security holdings or otherwise, in the Proposed Max
Amalgamation.
-23-
UNAUDITED
CONDENSED CONSOLIDATED PRO FORMA FINANCIAL INFORMATION
The following unaudited condensed consolidated pro forma
financial information is intended to provide you with
information about how the acquisition of IPC might have affected
the historical financial statements of Validus if it had been
consummated at an earlier time. The unaudited condensed
consolidated pro forma information has been prepared using
IPCs publicly available financial statements and
disclosures, without the benefit of inspection of IPCs
books and records. Therefore, certain pro forma adjustments,
such as recording fair value of assets and liabilities and
adjustments for consistency of accounting policy, are not
reflected in these unaudited condensed consolidated pro forma
financial statements. The following unaudited condensed
consolidated pro forma financial information does not
necessarily reflect the financial position or results of
operations that would have actually resulted had the acquisition
occurred as of the dates indicated, nor should they be taken as
necessarily indicative of the future financial position or
results of operations of Validus.
You should read the following condensed consolidated pro forma
financial information in conjunction with Validus Annual
Report on
Form 10-K
for the year ended December 31, 2008 and IPCs Annual
Report on
Form 10-K
for the year ended December 31, 2008, each as filed with
the Securities and Exchange Commission.
-24-
The following table presents unaudited condensed consolidated
pro forma balance sheet data at December 31, 2008
(expressed in thousands of U.S. dollars, except share and
per share data).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Historical
|
|
|
|
|
|
Pro Forma
|
|
|
|
|
|
|
|
|
|
Validus
|
|
|
Historical IPC
|
|
|
Purchase
|
|
|
|
|
|
Pro Forma
|
|
|
|
Holdings, Ltd.
|
|
|
Holdings, Ltd.
|
|
|
adjustments
|
|
|
Notes
|
|
|
Consolidated
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities, at fair value
|
|
$
|
2,454,501
|
|
|
$
|
1,793,020
|
|
|
$
|
|
|
|
|
|
|
|
$
|
4,247,521
|
|
Short-term investments, at fair value
|
|
|
377,036
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
377,036
|
|
Equity investments, at fair value
|
|
|
|
|
|
|
365,147
|
|
|
|
|
|
|
|
|
|
|
|
365,147
|
|
Cash and cash equivalents
|
|
|
449,848
|
|
|
|
77,020
|
|
|
|
(85,000
|
)
|
|
|
3(a)
|
|
|
|
441,868
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investments and cash
|
|
|
3,281,385
|
|
|
|
2,235,187
|
|
|
|
(85,000
|
)
|
|
|
|
|
|
|
5,431,572
|
|
Premiums receivable
|
|
|
408,259
|
|
|
|
108,033
|
|
|
|
|
|
|
|
|
|
|
|
516,292
|
|
Deferred acquisition costs
|
|
|
108,156
|
|
|
|
9,341
|
|
|
|
|
|
|
|
|
|
|
|
117,497
|
|
Prepaid reinsurance premiums
|
|
|
22,459
|
|
|
|
2,165
|
|
|
|
|
|
|
|
|
|
|
|
24,624
|
|
Securities lending collateral
|
|
|
98,954
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98,954
|
|
Loss reserves recoverable
|
|
|
208,796
|
|
|
|
2,771
|
|
|
|
|
|
|
|
|
|
|
|
211,567
|
|
Paid losses recoverable
|
|
|
1,388
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,388
|
|
Net receivable for investments sold
|
|
|
490
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
490
|
|
Accrued investment income
|
|
|
20,433
|
|
|
|
27,717
|
|
|
|
|
|
|
|
|
|
|
|
48,150
|
|
Current taxes recoverable
|
|
|
1,365
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,365
|
|
Intangible assets
|
|
|
127,217
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
127,217
|
|
Goodwill
|
|
|
20,393
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,393
|
|
Other assets
|
|
|
23,185
|
|
|
|
3,474
|
|
|
|
|
|
|
|
|
|
|
|
26,659
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
4,322,480
|
|
|
$
|
2,388,688
|
|
|
$
|
(85,000
|
)
|
|
|
|
|
|
$
|
6,626,168
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unearned premiums
|
|
$
|
539,450
|
|
|
$
|
85,473
|
|
|
|
|
|
|
|
|
|
|
$
|
624,923
|
|
Reserve for losses and loss expense
|
|
|
1,305,303
|
|
|
|
355,893
|
|
|
|
|
|
|
|
|
|
|
|
1,661,196
|
|
Reinsurance balances payable
|
|
|
33,042
|
|
|
|
628
|
|
|
|
|
|
|
|
|
|
|
|
33,670
|
|
Deferred taxation
|
|
|
21,779
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,779
|
|
Securities lending payable
|
|
|
105,688
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
105,688
|
|
Bank loan payable
|
|
|
|
|
|
|
75,000
|
|
|
|
|
|
|
|
|
|
|
|
75,000
|
|
Accounts payable and accrued expenses
|
|
|
74,184
|
|
|
|
20,747
|
|
|
|
|
|
|
|
|
|
|
|
94,931
|
|
Debentures payable
|
|
|
304,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
304,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
2,383,746
|
|
|
|
537,741
|
|
|
|
|
|
|
|
|
|
|
|
2,921,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares
|
|
|
13,235
|
|
|
|
561
|
|
|
|
11,328
|
|
|
|
3(a), 3(b), 3(c)
|
|
|
|
25,124
|
|
Additional paid-in capital
|
|
|
1,412,635
|
|
|
|
1,089,002
|
|
|
|
591,431
|
|
|
|
3(a), 3(b), 3(c)
|
|
|
|
3,093,068
|
|
Accumulated other comprehensive loss
|
|
|
(7,858
|
)
|
|
|
(876
|
)
|
|
|
876
|
|
|
|
3(c)
|
|
|
|
(7,858
|
)
|
Retained earnings
|
|
|
520,722
|
|
|
|
762,260
|
|
|
|
(688,635
|
)
|
|
|
3(a), 3(c), 3(e)
|
|
|
|
594,347
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
1,938,734
|
|
|
|
1,850,947
|
|
|
|
(85,000
|
)
|
|
|
|
|
|
|
3,704,681
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
4,322,480
|
|
|
$
|
2,388,688
|
|
|
$
|
(85,000
|
)
|
|
|
|
|
|
$
|
6,626,168
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares outstanding
|
|
|
75,624,697
|
|
|
|
55,943,297
|
|
|
|
67,338,947
|
|
|
|
|
|
|
|
142,963,644
|
|
Common shares and common share equivalents outstanding
|
|
|
90,091,403
|
|
|
|
56,440,530
|
|
|
|
67,937,467
|
|
|
|
|
|
|
|
158,028,870
|
|
Book value per share
|
|
$
|
25.64
|
|
|
$
|
33.09
|
|
|
|
|
|
|
|
7
|
|
|
$
|
25.91
|
|
Diluted book value per share
|
|
$
|
23.78
|
|
|
$
|
32.79
|
|
|
|
|
|
|
|
7
|
|
|
$
|
24.73
|
|
Diluted tangible book value per share
|
|
$
|
22.14
|
|
|
$
|
32.79
|
|
|
|
|
|
|
|
|
|
|
$
|
23.80
|
|
-25-
The following table sets forth unaudited condensed consolidated
pro forma results of operations for the year ended
December 31, 2008 (expressed in thousands of
U.S. dollars, except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Historical Validus
|
|
|
Historical IPC
|
|
|
Pro Forma Pur-
|
|
|
|
|
|
Pro Forma
|
|
|
|
Holdings, Ltd.
|
|
|
Holdings, Ltd.
|
|
|
chase adjustments
|
|
|
Notes
|
|
|
Consolidated
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross premiums written
|
|
$
|
1,362,484
|
|
|
$
|
403,395
|
|
|
$
|
(251
|
)
|
|
|
3(d
|
)
|
|
$
|
1,765,628
|
|
Reinsurance premiums ceded
|
|
|
(124,160
|
)
|
|
|
(6,122
|
)
|
|
|
251
|
|
|
|
3(d
|
)
|
|
|
(130,031
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums written
|
|
|
1,238,324
|
|
|
|
397,273
|
|
|
|
|
|
|
|
|
|
|
|
1,635,597
|
|
Change in unearned premiums
|
|
|
18,194
|
|
|
|
(9,906
|
)
|
|
|
|
|
|
|
|
|
|
|
8,288
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums earned
|
|
|
1,256,518
|
|
|
|
387,367
|
|
|
|
|
|
|
|
|
|
|
|
1,643,885
|
|
Net investment income
|
|
|
139,528
|
|
|
|
94,105
|
|
|
|
(2,438
|
)
|
|
|
3(a
|
)
|
|
|
231,195
|
|
Realized gain on repurchase of debentures
|
|
|
8,752
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,752
|
|
Net realized (losses) gains on investments
|
|
|
(1,591
|
)
|
|
|
(168,208
|
)
|
|
|
|
|
|
|
|
|
|
|
(169,799
|
)
|
Net unrealized (losses) gains on investments
|
|
|
(79,707
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(79,707
|
)
|
Other income
|
|
|
5,264
|
|
|
|
65
|
|
|
|
|
|
|
|
|
|
|
|
5,329
|
|
Foreign exchange gains (losses)
|
|
|
(49,397
|
)
|
|
|
(1,848
|
)
|
|
|
|
|
|
|
|
|
|
|
(51,245
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
1,279,367
|
|
|
|
311,481
|
|
|
|
(2,438
|
)
|
|
|
|
|
|
|
1,588,410
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Losses and loss expense
|
|
|
772,154
|
|
|
|
155,632
|
|
|
|
|
|
|
|
|
|
|
|
927,786
|
|
Policy acquisition costs
|
|
|
234,951
|
|
|
|
36,429
|
|
|
|
|
|
|
|
|
|
|
|
271,380
|
|
General and administrative expenses
|
|
|
123,948
|
|
|
|
20,689
|
|
|
|
|
|
|
|
|
|
|
|
144,637
|
|
Share compensation expense
|
|
|
27,097
|
|
|
|
5,625
|
|
|
|
|
|
|
|
|
|
|
|
32,722
|
|
Finance expenses
|
|
|
57,318
|
|
|
|
2,659
|
|
|
|
|
|
|
|
|
|
|
|
59,977
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
(1,215,468
|
)
|
|
|
(221,034
|
)
|
|
|
|
|
|
|
|
|
|
|
(1,436,502
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before taxes
|
|
|
63,899
|
|
|
|
90,447
|
|
|
|
(2,438
|
)
|
|
|
|
|
|
|
151,908
|
|
Income tax expense
|
|
|
(10,788
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,788
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before taxes
|
|
$
|
53,111
|
|
|
$
|
90,447
|
|
|
$
|
(2,438
|
)
|
|
|
|
|
|
$
|
141,120
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred dividend and warrant dividend
|
|
|
6,947
|
|
|
|
14,939
|
|
|
|
(14,939
|
)
|
|
|
3(f
|
)
|
|
|
6,947
|
|
Net income available to common shareholders
|
|
$
|
46,164
|
|
|
$
|
75,508
|
|
|
$
|
12,501
|
|
|
|
|
|
|
$
|
134,173
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares and common share
equivalents outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
74,677,903
|
|
|
|
52,124,034
|
|
|
|
67,338,947
|
|
|
|
|
|
|
|
142,016,850
|
|
Diluted
|
|
|
75,819,413
|
|
|
|
59,301,939
|
|
|
|
67,937,467
|
|
|
|
|
|
|
|
143,756,880
|
|
Basic earnings per share
|
|
$
|
0.62
|
|
|
$
|
1.45
|
|
|
|
|
|
|
|
6
|
|
|
$
|
0.94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share
|
|
$
|
0.61
|
|
|
$
|
1.45
|
|
|
|
|
|
|
|
6
|
|
|
$
|
0.93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-26-
Validus
Holdings, Ltd.
Notes To Unaudited Condensed Consolidated Pro Forma Financial
Statements (unaudited)
(Expressed in thousands of U.S. dollars, except share and per
share data)
The unaudited condensed consolidated pro forma financial
information gives effect to the proposed acquisition as if it
had occurred at December 31, 2008 for the purposes of the
unaudited condensed consolidated pro forma balance sheet and at
January 1, 2008 for the purposes of the unaudited condensed
consolidated pro forma statement of operations for the year
ended December 31, 2008. The unaudited condensed
consolidated pro forma financial information has been prepared
by Validus management and is based on Validus
historical consolidated financial statements and IPCs
historical consolidated financial statements. Certain amounts
from IPCs historical consolidated financial statements
have been reclassified to conform to the Validus presentation.
The unaudited condensed consolidated pro forma financial
statements have been prepared using IPCs publicly
available financial statements and disclosures, without the
benefit of inspection of IPCs books and records or
discussion with the IPC management team. Therefore, certain pro
forma adjustments, such as recording fair value of assets and
liabilities and adjustments for consistency of accounting
policy, are not reflected in these unaudited condensed
consolidated pro forma financial statements. Additional
reclassifications of IPC data to conform to the Validus
presentation may also be required.
This unaudited condensed consolidated pro forma financial
information is prepared in conformity with US GAAP. The
unaudited condensed consolidated pro forma balance sheet as of
December 31, 2008 and the unaudited condensed consolidated
pro forma statement of operations for the year ended
December 31, 2008 have been prepared using the following
information:
(a) Audited historical consolidated financial statements of
Validus as of December 31, 2008 and for the year ended
December 31, 2008;
(b) Audited historical consolidated financial statements of
IPC as of December 31, 2008 and for the year ended
December 31, 2008;
(c) Such other known supplementary information as
considered necessary to reflect the acquisition in the unaudited
condensed consolidated pro forma financial information.
The pro forma adjustments reflecting the acquisition of IPC
under the purchase method of accounting are based on certain
estimates and assumptions. The unaudited condensed consolidated
pro forma adjustments may be revised as additional information
becomes available. The actual adjustments upon consummation of
the acquisition and the allocation of the final purchase price
of IPC will depend on a number of factors, including additional
financial information available at such time, changes in values
and changes in IPCs operating results between the date of
preparation of this unaudited condensed consolidated pro forma
financial information and the effective date of the acquisition.
Therefore, it is likely that the actual adjustments will differ
from the pro forma adjustments and it is possible the
differences may be material. Validus management believes
that its assumptions provide a reasonable basis for presenting
all of the significant effects of the transactions contemplated
based on information available to Validus at the time and that
the pro forma adjustments give appropriate effect to those
assumptions and are properly applied in the unaudited condensed
consolidated pro forma financial information.
The unaudited condensed consolidated pro forma financial
information does not include any financial benefits, revenue
enhancements or operating expense efficiencies arising from the
acquisition. In addition, the unaudited condensed consolidated
pro forma financial information does not include any additional
expenses that may result from the IPC acquisition. Estimated
costs of the transaction as well as the benefit of the negative
goodwill have been reflected in the unaudited condensed
consolidated pro forma balance sheets, but have not been
included on the pro forma income statement due to their
non-recurring nature.
The unaudited condensed consolidated pro forma financial
information is not intended to reflect the results of operations
or the financial position that would have resulted had the
acquisition been effected on the dates indicated and if the
companies had been managed as one entity. The unaudited
condensed consolidated pro forma financial
-27-
Validus Holdings, Ltd.
Notes To Unaudited Condensed Consolidated Pro Forma Financial
Statements (unaudited)
(Expressed in thousands of U.S. dollars, except share and per
share data) (Continued)
information should be read in conjunction with Validus
Annual Report on
Form 10-K
for the year ended December 31, 2008, as filed with the
Securities and Exchange Commission.
|
|
2.
|
Recent
Accounting Pronouncements
|
In December 2007, the FASB issued Statement No. 141(R),
Business Combinations (FAS 141(R))
which is effective for business combinations for which the
acquisition date is on or after the beginning of the first
annual reporting period beginning on or after December 15,
2008. On April 1, 2009 the FASB finalized and issued FSP
FAS 141(R)-1 which amended and clarified FAS 141 (R)
and is effective for business combinations whose acquisition
date is on or after January 1, 2009.
FSP FAS 141(R)-1 has amended FAS 141(R)s
guidance on the initial recognition and measurement, subsequent
measurement and accounting, and disclosure of assets acquired
and liabilities assumed in a business combination that arise
from contingencies.
Significant changes arising from FAS 141 (R) and FSP
FAS 141(R)-1 and impacting these pro forma financial
statements include the determination of the purchase price,
treatment of transaction expenses, restructuring costs and
negative goodwill as follows:
|
|
|
|
|
Purchase Price Previously, the date the business
combination was announced could be used as the effective date in
determining the purchase price. Under FAS 141(R), the
purchase price is determined as of the acquisition date, which
is the date that the acquirer obtains control;
|
|
|
|
|
|
Transaction Expenses Previously, costs associated
with purchase transactions could be capitalized and included as
part of transaction purchase price, adding to the amount of
goodwill recognized. Under FAS 141(R), all such costs must be
expensed as incurred;
|
|
|
|
|
|
Restructuring Costs Previously, restructuring costs
that were planned to occur after the closing of the transaction
were recognized and recorded at the closing date as a liability.
Under FAS 141(R), expected restructuring costs are not
recorded at the closing date, but rather after the transaction.
The only costs to be included as a liability at the closing
date, and therefore included as transaction costs,
are those for which an acquirer is obligated at the time of the
closing; and
|
|
|
|
Negative Goodwill/Bargain Purchases Previously, if
the total fair value of net assets acquired (assets less
liabilities assumed) exceeded the consideration paid, there was
a pro rata reduction of the assets assumed to allow the net
assets acquired to equal the consideration paid. Under
FAS 141(R), instead of allocating this negative
goodwill to reduce the carrying value of assets assumed,
the acquirer will book a gain as a result of the bargain
purchase, to be recognized through the income statement at the
close of the transaction.
|
On March 31, 2009, Validus announced that it delivered a
binding offer letter (the Offer Letter) to the Board
of Directors of IPC Holdings, Ltd. (IPC) pursuant to
which Validus and IPC would amalgamate (the
Amalgamation) in a share-for-share exchange valuing
IPC shares at an 18.0% premium to IPCs closing market
price on March 30, 2009, subject to the terms and
conditions set forth in the Offer Letter and in an Agreement and
Plan of Amalgamation (the Amalgamation Agreement)
that was signed by Validus and delivered to IPC with the Offer
Letter.
Validus proposed an amalgamation with IPC at an exchange ratio
of 1.2037 Validus shares per outstanding IPC share, providing a
value per IPC share of $29.98 or an 18.0% premium to IPCs
closing share price as of March 30, 2009 (the date
immediately preceding the deliverance of the Offer Letter).
-28-
Validus Holdings, Ltd.
Notes To Unaudited Condensed Consolidated Pro Forma Financial
Statements (unaudited)
(Expressed in thousands of U.S. dollars, except share and per
share data) (Continued)
The Board of Directors of Validus has unanimously approved the
submission of its binding offer and the delivery of the signed
Amalgamation Agreement so that, upon a termination of IPCs
Agreement and Plan of Amalgamation with Max Capital Group Ltd.,
dated as of March 1, 2009 and amended as of March 5,
2009 (the Max Plan of Amalgamation), IPC will be
able to sign the Amalgamation Agreement with the certainty of an
agreed transaction. Validus offer is structured as a
tax-free share-for-share transaction and does not require any
external financing. It is not conditioned on due diligence.
Validus has reserved the right to withdraw its binding offer if
the Board of Directors of IPC has not reached a determination
(i) that Validus binding offer constitutes a Superior
Proposal (as defined in the Max Plan of Amalgamation),
(ii) to withdraw its recommendation for the transaction
contemplated by the Max Plan of Amalgamation and (iii) to
make a recommendation for the transaction contemplated by
Validus binding offer by 5:00 p.m., Bermuda time, on
Wednesday, April 15, 2009. Validus has further reserved the
right to withdraw its binding offer if IPC subsequently
withdraws its recommendation in favor of Validus offer or
if IPC does not sign the Amalgamation Agreement within two
business days after the termination of the Max Plan of
Amalgamation.
In connection with the IPC acquisition, transaction costs
currently estimated at $35,000 will be incurred and expensed. Of
this amount, $15,000 relates to Validus expenses as set forth in
The Amalgamation Sources of Funds, Fees and
Expenses and $20,000 is our estimate of IPCs
expenses based on the IPC/Max
S-4. In
addition, upon termination of IPCs Agreement and Plan of
Amalgamation with Max Capital Group Ltd., a
break-up fee
of $50,000 (the Max Termination Fee)
will be incurred and expensed.
As discussed above, these pro forma purchase adjustments are
based on certain estimates and assumptions made as of the date
of the unaudited condensed consolidated pro forma financial
information. The actual adjustments will depend on a number of
factors, including changes in the estimated fair value of net
balance sheet assets and operating results of IPC between
December 31, 2008 and the effective date of the
acquisition. Validus expects to make such adjustments at the
effective date of the acquisition. These adjustments are likely
to be different from the adjustments made to prepare the
unaudited condensed consolidated pro forma financial information
and such differences may be material.
The share prices for both Validus and IPC used in determining
the preliminary estimated purchase price are based on the
closing share prices on March 30, 2009 (the date
immediately preceding the deliverance of the Offer Letter). The
preliminary total purchase price is calculated as follows:
|
|
|
|
|
Calculation of Total Purchase Price
|
|
|
|
|
IPC common shares outstanding as of February 23, 2009
|
|
|
55,943,297
|
|
IPC shares issued pursuant to option exercises
|
|
|
3,818
|
|
IPC shares issued following vesting of restricted shares, RSUs
and PSUs
|
|
|
493,415
|
|
|
|
|
|
|
Total IPC common shares prior to transaction
|
|
|
56,440,530
|
|
Exchange ratio
|
|
|
1.2037
|
|
|
|
|
|
|
Total Validus common shares to be issued
|
|
|
67,937,467
|
|
Validus closing share price on March 30, 2009
|
|
$
|
24.91
|
|
|
|
|
|
|
Total purchase price(a)
|
|
$
|
1,692,322
|
|
The allocation of the purchase price is as follows:
|
|
|
|
|
Allocation of Purchase Price
|
|
|
|
|
IPC shareholders equity(b)
|
|
$
|
1,850,947
|
|
Total purchase price
|
|
$
|
1,692,322
|
|
|
|
|
|
|
Negative goodwill (a b)
|
|
$
|
158,625
|
|
|
|
|
|
|
-29-
Validus Holdings, Ltd.
Notes To Unaudited Condensed Consolidated Pro Forma Financial
Statements (unaudited)
(Expressed in thousands of U.S. dollars, except share and per
share data) (Continued)
|
|
|
(a) |
|
In connection with the IPC acquisition, 67,937,467 shares
are expected to be issued resulting in additional share capital
of $11,889 and Additional Paid-In Capital of $1,680,433. |
|
|
|
In addition, transaction costs currently estimated at $35,000
and the Max Termination Fee of $50,000 will be incurred and
expensed by the consolidated entity. Based on an expected
investment return of 3.75%, investment income of $2,438 would
have been foregone during 2008 had these payments been made. |
|
(b) |
|
Employees of IPC hold 526,000 options to purchase IPC shares.
These options would vest upon a change in control, and would be
exercisable. The exercise price range of these options is from
$13 to $49, with a weighted average of $34.31. It is expected
that 3,818 net shares would be issued upon exercise of
these options. |
|
(c) |
|
Elimination of IPCs Ordinary Shares of $561, Additional
Paid in Capital of $1,089,002, Accumulated Other Comprehensive
Loss of $876 and Retained Earnings of $762,260. |
|
(d) |
|
A related party balance of $251 representing reinsurance ceded
to IPC by Validus was eliminated from gross premiums written and
reinsurance ceded. These policies were fully earned and expensed
respectively at year end and had no other effect on the pro
forma financial statements. |
|
(e) |
|
The unaudited condensed consolidated pro forma financial
statements have been prepared using IPCs publicly
available financial statements and disclosures, without the
benefit of inspection of IPCs books and records.
Therefore, the carrying value of assets and liabilities in
IPCs financial statements are considered to be a proxy for
fair value of those assets and liabilities, with the difference
between the net assets and the total purchase price considered
to be negative goodwill. In addition, certain pro forma
adjustments, such as recording fair value of assets and
liabilities and adjustments for consistency of accounting
policy, are not reflected in these unaudited pro forma
consolidated financial statements. In December 2007, the
Financial Accounting Standards Board (FASB) issued
Statement No. 141(R), Business Combinations
(FAS 141(R)) This Statement defines a bargain
purchase as a business combination in which the total
acquisition-date fair value of the identifiable net assets
acquired exceeds the fair value of the consideration transferred
plus any noncontrolling interest in the acquiree, and it
requires the acquirer to recognize that excess in earnings as a
gain attributable to the acquirer. Negative goodwill of $158,625
has been recorded as a credit to retained earnings as upon
completion of the amalgamation negative goodwill will be treated
as a gain in the consolidated statement of operations. |
|
(f) |
|
On November 15, 2008, IPCs 9,000,000 Series A
Mandatory Convertible preferred shares automatically converted
pursuant to their terms into 9,129,600 common shares. Therefore,
dividends of $14,939 on these preferred shares of IPC have been
eliminated from the unaudited pro forma results of operations. |
-30-
Validus Holdings, Ltd.
Notes To Unaudited Condensed Consolidated Pro Forma Financial
Statements (unaudited)
(Expressed in thousands of U.S. dollars, except share and per
share data) (Continued)
|
|
4.
|
Gross
Premiums Written
|
The following table sets forth the gross premiums written by
Validus, IPC and pro forma combined:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase
|
|
|
|
|
Validus Re
|
|
Validus
|
|
|
IPC(a)
|
|
|
Adjustments
|
|
|
Combined
|
|
|
Property Cat XOL(b)
|
|
$
|
328,216
|
|
|
$
|
333,749
|
|
|
$
|
|
|
|
$
|
661,965
|
|
Property Per Risk XOL
|
|
|
54,056
|
|
|
|
10,666
|
|
|
|
|
|
|
|
64,722
|
|
Property Proportional(c)
|
|
|
110,695
|
|
|
|
|
|
|
|
|
|
|
|
110,695
|
|
Marine
|
|
|
117,744
|
|
|
|
|
|
|
|
|
|
|
|
117,744
|
|
Aerospace
|
|
|
39,323
|
|
|
|
18,125
|
|
|
|
(151
|
)
|
|
|
57,297
|
|
Life and A&H
|
|
|
1,009
|
|
|
|
|
|
|
|
|
|
|
|
1,009
|
|
Financial Institutions
|
|
|
4,125
|
|
|
|
|
|
|
|
|
|
|
|
4,125
|
|
Other
|
|
|
|
|
|
|
8,318
|
|
|
|
(100
|
)
|
|
|
8,218
|
|
Terrorism
|
|
|
25,502
|
|
|
|
|
|
|
|
|
|
|
|
25,502
|
|
Workers Comp
|
|
|
7,101
|
|
|
|
|
|
|
|
|
|
|
|
7,101
|
|
Total Validus Re Segment
|
|
|
687,771
|
|
|
|
370,858
|
|
|
|
(251
|
)
|
|
|
1,058,378
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Talbot
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property
|
|
|
152,143
|
|
|
|
|
|
|
|
|
|
|
|
152,143
|
|
Marine
|
|
|
287,694
|
|
|
|
|
|
|
|
|
|
|
|
287,694
|
|
Aviation & Other
|
|
|
40,028
|
|
|
|
|
|
|
|
|
|
|
|
40,028
|
|
Accident & Health
|
|
|
18,314
|
|
|
|
|
|
|
|
|
|
|
|
18,314
|
|
Financial Institutions
|
|
|
42,263
|
|
|
|
|
|
|
|
|
|
|
|
42,263
|
|
War
|
|
|
128,693
|
|
|
|
|
|
|
|
|
|
|
|
128,693
|
|
Contingency
|
|
|
22,924
|
|
|
|
|
|
|
|
|
|
|
|
22,924
|
|
Bloodstock
|
|
|
16,937
|
|
|
|
|
|
|
|
|
|
|
|
16,937
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Talbot Segment
|
|
|
708,996
|
|
|
|
|
|
|
|
|
|
|
|
708,996
|
|
Intersegment revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property
|
|
|
(21,724
|
)
|
|
|
|
|
|
|
|
|
|
|
(21,724
|
)
|
Marine
|
|
|
(8,543
|
)
|
|
|
|
|
|
|
|
|
|
|
(8,543
|
)
|
Specialty
|
|
|
(4,016
|
)
|
|
|
|
|
|
|
|
|
|
|
(4,016
|
)
|
Total Intersegment Revenue Eliminated
|
|
|
(34,283
|
)
|
|
|
|
|
|
|
|
|
|
|
(34,283
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments for reinstatement premium
|
|
|
|
|
|
|
32,537
|
|
|
|
|
|
|
|
32,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,362,484
|
|
|
$
|
403,395
|
|
|
$
|
(251
|
)
|
|
$
|
1,765,628
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
For IPC, this includes annual (deposit) and adjustment premiums.
Excludes reinstatement premiums of $32,537 which are not
classified by class of business by IPC. |
|
|
|
(b) |
|
For Validus, Cat XOL is comprised of Catastrophe XOL, Aggregate
XOL, RPP, Per Event XOL, Second Event and Third Event covers.
For IPC, this includes Catastrophe XOL and Retrocessional. |
|
(c) |
|
Proportional is comprised of Quota Share and Surplus Share. |
-31-
Validus Holdings, Ltd.
Notes To Unaudited Condensed Consolidated Pro Forma Financial
Statements (unaudited)
(Expressed in thousands of U.S. dollars, except share and per
share data) (Continued)
Selected ratios of Validus, IPC and pro forma combined are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma
|
|
|
|
Validus
|
|
|
IPC
|
|
|
combined
|
|
|
Losses and loss expenses ratios
|
|
|
61.5
|
%
|
|
|
40.2
|
%
|
|
|
56.4
|
%
|
Policy acquisition costs ratios
|
|
|
18.7
|
|
|
|
9.4
|
|
|
|
16.5
|
|
General and administrative cost ratios
|
|
|
12.0
|
|
|
|
6.8
|
|
|
|
10.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined ratio
|
|
|
92.2
|
%
|
|
|
56.4
|
%
|
|
|
83.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
Factors affecting the Validus 2008 Loss Ratio |
|
|
|
The loss ratio, which is defined as losses and loss expenses
divided by net premiums earned, for the year ended
December 31, 2008 was 61.5%. During the year ended
December 31, 2008, the frequency and severity of worldwide
losses that materially affected Validus loss ratio
increased. During the year ended December 31, 2008, Validus
incurred $260,567 and $22,141 of loss expense attributable to
Hurricanes Ike and Gustav, which represent 20.7 and
1.8 percentage points of the loss ratio, respectively.
Other notable loss events added $45,895 of 2008 loss expense or
3.7 percentage points of the loss ratio bringing the total
effect of aforementioned events on the 2008 loss ratio to
26.2 percentage points. Favorable loss development on prior
years totaled $69,702. Favorable loss reserve development
benefited Validus loss ratio for the year ended
December 31, 2008 by 5.5 percentage points. |
|
(b) |
|
Factors affecting the IPC 2008 Loss Ratio |
|
|
|
|
|
The data in the following paragraph is taken from
Managements Discussion and Analysis of Financial
Condition and Results of Operations contained in
IPCs Annual Report on
Form 10-K
for the year ended December 31, 2008. Such disclosure was
not made in thousands of U.S. dollars, and the data
has been reproduced here as it was originally presented. |
|
|
|
|
|
IPCs loss ratio, which is defined as losses and loss
expenses divided by net premiums earned, for the year ended
December 31, 2008 was 40.2%. IPC incurred net losses and
loss adjustment expenses of $155.6 million for the year
ended December 31, 2008. Total net losses for the year
ended December 31, 2008 relating to the current year were
$206.6 million, while reductions to estimates of ultimate
net loss for prior year events were $50.9 million. During
2008, IPCs incurred losses included: $23.0 million
from the Alon Refinery explosion in Texas, a storm that affected
Queensland, Australia, and Windstorm Emma that affected parts of
Europe, which all occurred in the first quarter of 2008;
$10.5 million from the flooding in Iowa in June and
tornadoes that affected the mid-west United States in May 2008;
together with $160.0 million from Hurricane Ike and
$7.6 million from Hurricane Gustav, which both occurred in
September 2008. The impact on IPCs 2008 loss ratio from
these events was 51.9 percentage points. The losses from
these events were partly offset by reductions to IPCs
estimates of ultimate loss for a number of prior year events,
including $11.0 million for Hurricane Katrina,
$18.6 million for the storm and flooding that affected New
South Wales, Australia in 2007 and $22.8 million for the
floods that affected parts of the U.K. in June and July 2007.
The cumulative $52.4 million of favorable loss reserve
development benefited the IPCs loss ratio for the year
ended December 31, 2008 by 13.5 percentage points. |
-32-
Validus Holdings, Ltd.
Notes To Unaudited Condensed Consolidated Pro Forma Financial
Statements (unaudited)
(Expressed in thousands of U.S. dollars, except share and per
share data) (Continued)
|
|
6.
|
Earnings
per Common Share
|
(a) Pro forma earnings per common share for the year ended
December 31, 2008 has been calculated based on the
estimated weighted average number of common shares outstanding
on a pro forma basis, as described in 6(b) below. The historical
weighted average number of common shares outstanding of Validus
was 74,677,903 and 75,819,413 basic and diluted, respectively,
for the year ended December 31, 2008.
(b) The pro forma weighted average number of common shares
outstanding for the year ended December 31, 2008, after
giving effect to the exchange of shares as if the acquisition
shares had been issued and outstanding for the whole year, is
142,016,850 and 143,756,880, basic and diluted, respectively.
(c) The following table sets forth the computation of basic
and diluted earnings per share for the year ended
December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
Historical
|
|
|
|
|
|
|
Validus
|
|
|
Pro Forma
|
|
|
|
Holdings
|
|
|
Consolidated
|
|
|
Net income available to common shareholders
|
|
$
|
46,164
|
|
|
$
|
134,173
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares basic ordinary shares
outstanding
|
|
|
74,677,903
|
|
|
|
142,016,850
|
|
Share equivalents Warrants
|
|
|
|
|
|
|
|
|
Restricted Shares
|
|
|
1,004,809
|
|
|
|
1,598,733
|
|
Options
|
|
|
136,701
|
|
|
|
141,297
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares diluted
|
|
|
75,819,413
|
|
|
|
143,756,880
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share
|
|
$
|
0.62
|
|
|
$
|
0.94
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share
|
|
$
|
0.61
|
|
|
$
|
0.93
|
|
|
|
|
|
|
|
|
|
|
-33-
Validus Holdings, Ltd.
Notes To Unaudited Condensed Consolidated Pro Forma Financial
Statements (unaudited)
(Expressed in thousands of U.S. dollars, except share and per
share data) (Continued)
Validus calculates diluted book value per share using the
as-if-converted method, where all proceeds received
upon exercise of warrants and stock options would be retained by
Validus and the resulting common shares from exercise remain
outstanding. In its public records, IPC calculates diluted book
value per share using the treasury stock method,
where proceeds received upon exercise of warrants and stock
options would be used by IPC to repurchase shares from the
market, with the net common shares from exercise remaining
outstanding. Accordingly, for the purposes of the Pro Forma
Condensed Consolidated Financial Statements and notes thereto,
IPCs diluted book value per share has been recalculated
based on the as-if-converted method to be consistent
with Validus calculation.
The following table sets forth the computation of book value and
diluted book value per share adjusted for the Amalgamation:
|
|
|
|
|
|
|
|
|
|
|
Historical
|
|
|
|
|
|
|
Validus
|
|
|
Pro Forma
|
|
|
|
Holdings
|
|
|
Consolidated
|
|
|
Book value per common share calculation
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
$
|
1,938,734
|
|
|
$
|
3,704,681
|
|
Shares
|
|
|
75,624,697
|
|
|
|
142,963,644
|
|
Book value per common share
|
|
$
|
25.64
|
|
|
$
|
25.91
|
|
|
|
|
|
|
|
|
|
|
Diluted book value per common share calculation
|
|
|
|
|
|
|
|
|
Total Shareholders equity
|
|
$
|
1,938,734
|
|
|
$
|
3,704,681
|
|
Proceeds of assumed exercise of outstanding warrants
|
|
$
|
152,315
|
|
|
$
|
152,316
|
|
Proceeds of assumed exercise of outstanding stock options
|
|
$
|
51,043
|
|
|
$
|
51,043
|
|
Unvested restricted shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,142,093
|
|
|
$
|
3,908,040
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
75,624,697
|
|
|
|
142,963,644
|
|
Warrants
|
|
|
8,680,149
|
|
|
|
8,680,149
|
|
Options
|
|
|
2,799,938
|
|
|
|
2,804,534
|
|
Unvested restricted shares
|
|
|
2,986,619
|
|
|
|
3,580,543
|
|
|
|
|
90,091,403
|
|
|
|
158,028,870
|
|
|
|
|
|
|
|
|
|
|
Diluted book value per common share
|
|
$
|
23.78
|
|
|
$
|
24.73
|
|
-34-
Validus Holdings, Ltd.
Notes To Unaudited Condensed Consolidated Pro Forma Financial
Statements (unaudited)
(Expressed in thousands of U.S. dollars, except share and per
share data) (Continued)
The following table sets forth the computation of debt to total
capitalization and debt (excluding debentures payable) to total
capitalization, adjusted for the Amalgamation:
|
|
|
|
|
|
|
|
|
|
|
Historical
|
|
|
|
|
|
|
Validus
|
|
|
Pro Forma
|
|
|
|
Holdings
|
|
|
Consolidated
|
|
|
Total debt
|
|
|
|
|
|
|
|
|
Bank loan payable
|
|
$
|
|
|
|
$
|
75,000
|
|
Borrowings drawn under credit facility
|
|
|
|
|
|
|
|
|
Debentures payable
|
|
|
304,300
|
|
|
|
304,300
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
$
|
304,300
|
|
|
$
|
379,300
|
|
|
|
|
|
|
|
|
|
|
Total capitalization
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
$
|
1,938,734
|
|
|
$
|
3,704,681
|
|
Bank loan payable
|
|
|
|
|
|
|
75,000
|
|
Borrowings drawn under credit facility
|
|
|
|
|
|
|
|
|
Debentures payable
|
|
|
304,300
|
|
|
|
304,300
|
|
|
|
|
|
|
|
|
|
|
Total capitalization
|
|
$
|
2,243,034
|
|
|
$
|
4,083,981
|
|
|
|
|
|
|
|
|
|
|
Total debt to total capitalization
|
|
|
13.6
|
%
|
|
|
9.3
|
%
|
Debt (excluding debentures payable) to total capitalization
|
|
|
0.0
|
%
|
|
|
1.8
|
%
|
-35-
THE
PROPOSED VALIDUS AMALGAMATION
In connection with the delivery of the Validus Offer to the
Company, Validus delivered a signed amalgamation agreement that
would be binding on Validus upon countersignature by the
Company. The proposed Validus amalgamation agreement (the
Validus Agreement), and a description thereof, were
filed with the SEC on
Form 8-K
on March 31, 2009. For the full terms of the Validus
Agreement we refer you to that filing. Validus has reserved the
right to withdraw its offer if the Company has not signed the
Validus Agreement by 5 p.m. on the second business day
after the termination of the Max Amalgamation Agreement.
The Validus Offer is subject to a number of conditions,
including the termination of the Max Amalgamation Agreement,
receipt of regulatory approvals, receipt of amendments or
waivers under the Companys and Validus credit
facilities and the approval of the issuance of the necessary
Validus shares by our shareholders. As a result, the
Companys shareholders cannot be guaranteed that any
premium will be paid to them based solely on their rejection of
the Proposed Max Amalgamation. However, there are no assurances
that this timeframe will be met or that all of the conditions to
the Validus Offer will be satisfied. Shareholders should take
all of these factors into account when determining how to vote
their Shares.
The Companys shareholders should also consider the risks
that may be associated with an investment in our common shares
and with the transaction contemplated by the Validus Offer.
These factors are set forth in the Forward-Looking
Statements section of this proxy statement and are
described in more detail in the section entitled Risk
Factors in our Annual Report or
Form 10-K
for the year ended December 31, 2008, which has been filed
with the SEC and is available to the Companys
shareholders. The Companys shareholders may obtain a copy
of our annual report free of charge at the SECs website
(www.sec.gov) or by directing a request to Georgeson Inc. at
(888) 274-5119
or by email at validusIPC@georgeson.com.
-36-
Comparison
of Terms between Max Amalgamation Agreement and Validus
Agreement
The Validus Agreement was substantially the same as the Max
Amalgamation Agreement, as Validus board of directors
determined that proposing substantially similar agreement terms
would facilitate the IPC Boards evaluation of the Validus
Offer and by proposing substantially similar agreement terms and
improved economic terms to IPC, the IPC Board would be more
likely to conclude that the Validus offer could be reasonably
likely to constitute a Superior Proposal pursuant to
the terms of the Max Amalgamation Agreement. In addition to the
modifications reflecting the different consideration Validus is
offering to IPC shareholders and the shareholder votes that will
be required, as well as the elimination of references to Max,
the significant differences in the two agreements are described
below. We encourage you to read the full text of the agreements,
since the agreements, and not this summary, govern the proposed
transactions. The Max Amalgamation Agreement is included as
Annex A and Annex B to the IPC/Max
S-4. The
Validus Agreement is filed as Exhibit 99.2 to the Validus
Form 8-K
filed with the SEC on March 31, 2009 regarding the delivery
of the Validus Offer to the Board of Directors of IPC.
Restrictions
on Solicitation of Acquisition Proposals and Discussions
regarding Acquisition Proposals
|
|
|
Max Amalgamation Agreement
|
|
Validus Agreement
|
|
The Max Amalgamation Agreement precludes IPC and Max and their
respective subsidiaries and advisors from directly or
indirectly, initiating, soliciting, encouraging or facilitating
(including by providing information) any effort or attempt to
make or implement any proposal or offer with respect to an
amalgamation, reorganization, consolidation, business
combination or similar transaction involving it or any of its
subsidiaries or any purchase or sale involving 10% or more of
its consolidated assets (including, without limitation, shares
of their respective subsidiaries), or 10% or more of its total
voting power or the voting power of any of their respective
subsidiaries or from discussing any such proposal with any
person.
|
|
The Validus Agreement provides that IPC and its subsidiaries are
subject to similar restrictions but does not restrict Validus,
its subsidiaries and advisors.
|
Covenants
Relating to the Conduct of Business
|
|
|
Max Amalgamation Agreement
|
|
Validus Agreement
|
|
Each of the covenants applies to both IPC and Max.
|
|
Each of the covenants applies to both IPC and Validus except
that in the Validus Agreement, IPC and not Validus, would be
prohibited from (i) repurchasing, redeeming or otherwise
acquiring its outstanding common shares prior to the effective
time of the amalgamation and (ii) engaging in certain
actions in connection with its employee compensation and benefit
plans.
|
-37-
Conditions
to the Amalgamation
|
|
|
Max Amalgamation Agreement
|
|
Validus Agreement
|
|
The conditions to the Max Amalgamation Agreement are set forth
in the IPC/Max
S-4 under
The Amalgamation Conditions to the
Amalgamation.
|
|
The conditions to the amalgamation set forth in the Validus
Agreement are substantially similar to those set forth in the
Max Amalgamation Agreement, except that Validus obligation
to consummate the amalgamation is subject to the additional
fulfillment or waiver (by Validus) of the condition that all
amendments or waivers under IPCs credit facilities and
Validus credit facilities, as determined by Validus to be
necessary to consummate the amalgamation and the other
transactions contemplated thereby, shall be in full force and
effect.
|
Termination
|
|
|
Max Amalgamation Agreement
|
|
Validus Agreement
|
|
Either Max or IPC may terminate the Max Amalgamation Agreement
if the Proposed Max Amalgamation has not been consummated by
November 30, 2009.
|
|
Either IPC or Validus may terminate the Validus Agreement if the
amalgamation has not been consummated on or before the later of
(i) November 30, 2009 and (ii) five months of the date
of execution of the Validus Agreement by both IPC and Validus.
|
Termination
Fee
|
|
|
Max Amalgamation Agreement
|
|
Validus Agreement
|
|
$50 million.
|
|
$16 million.
|
OTHER MAX
AMALGAMATION PROPOSALS TO BE PRESENTED AT THE
ANNUAL GENERAL MEETING
In addition to soliciting proxies to approve Proposal #8 in
connection with the Proposed Max Amalgamation, the
Companys Board is also soliciting proxies for the Annual
General Meeting for certain other proposals in connection with
the Proposed Max Amalgamation (the Other Proposals).
All of these proposals are seeking shareholder approval of
matters required by the Max Amalgamation Agreement.
The Companys Proposals #1 through #5 is a
request to approve amendments to IPCs bye-laws to be
effective as of the effective time, and are collectively
referred to as the IPC bye-law amendments.
Specifically, they are to: (1) increase the maximum number
of directors on the board of directors from nine to 12,
(2) modify the indemnity provisions, (3) add
provisions regarding advance notice of shareholder nominees for
director and other shareholder proposals, (4) remove
provisions regarding alternate directors and cumulative voting
in the election of directors, and (5) add certain
conditions to the conduct of director meetings.
The Companys Proposal #6 is a request to approve,
effective as of the effective time, the increase in the
Companys authorized share capital from $1,850,000 to
$2,350,000 by the creation of an additional 50,000,000 common
shares, par value $0.01 per share, ranking pari passu
with the existing Company common shares.
The Companys Proposal #7 is a request to approve,
effective as of the effective time, a change in IPCs name
to Max Capital Group Ltd.
The Companys Proposal #10 is a request to approve,
effective as of the effective time, a revised plan of
remuneration for the combined entitys board of directors.
Each of these proposals is more fully described in the IPC/Max
S-4. In
addition to soliciting the proxies discussed above, the
Companys Board is also soliciting proxies for the Annual
General Meeting for a proposal to
-38-
approve any adjournment or postponement of the Annual General
Meeting, including if necessary, to solicit additional proxies
in favor of the adoption of the Max Amalgamation Agreement and
the approval of the Proposed Max Amalgamation if there are not
sufficient votes for that proposal (the Adjournment
Proposal). Because Proposals #1 through #8
and #10 and the Adjournment Proposal are designed to
facilitate the approval of the Proposed Max Amalgamation,
Validus recommends voting AGAINST these proposals.
YOU CAN CAST YOUR VOTE WITH RESPECT TO ALL PROPOSALS TO
BE CONSIDERED AT THE ANNUAL GENERAL MEETING ON OUR GOLD PROXY
CARD. THEREFORE, THERE IS NO NEED TO VOTE ON THE COMPANYS
PROXY CARD.
OTHER
PROPOSALS TO BE PRESENTED AT THE ANNUAL GENERAL
MEETING
In addition to soliciting proxies to approve matters related to
the Max Amalgamation, the Companys Board of Directors is
also soliciting proxies for the Annual General Meeting for a
proposal to elect directors and to appoint its independent
auditors. The Companys Proposal #9 is a request to
elect the directors of IPC and, at the effective time, of the
combined entity. Finally, the Companys Proposal #11
is a request to appoint KPMG as IPCs independent auditors
until the close of the next annual general meeting and to
authorize the audit committee of IPCs board of directors
to set the compensation of such independent auditors.
With respect to these Proposals, #9 and #11, we are
not making any recommendation as to how you should vote. If you
do not indicate your voting instructions for either of these
proposals we will vote to WITHHOLD with respect to
each of the nominees listed in Proposal #9 and to
ABSTAIN with respect to Proposal #11.
YOU CAN CAST YOUR VOTE WITH RESPECT TO ALL PROPOSALS TO
BE CONSIDERED AT THE ANNUAL GENERAL MEETING ON OUR GOLD PROXY
CARD. THEREFORE, THERE IS NO NEED TO VOTE ON THE COMPANYS
PROXY CARD.
Other than as set forth above, Validus is not currently aware of
any other proposals to be brought before the Annual General
Meeting. Should other proposals be brought before the Annual
General Meeting, the persons named on the GOLD proxy card will
abstain from voting on such proposals unless such proposals
adversely affect the interests of Validus as determined by
Validus in its sole discretion, in which event such persons will
vote on such proposals in their discretion.
VOTING
PROCEDURES
According to the IPC/Max
S-4, as of
the Record Date, there
were Shares
entitled to vote at the Annual General Meeting.
Under the Companys bye-laws, the presence, in person or by
proxy, of the holders of more than 50% of the Shares outstanding
as of the Record Date (without giving effect to the limitation
on voting rights of 10% shareholders) and entitled to vote at
the Annual General Meeting is necessary to constitute a quorum
at the Annual General Meeting. In accordance with Nasdaq rules,
brokers and nominees who hold Shares in street-name for
customers may not exercise their voting discretion with respect
to the Companys Proposals in connection with the Proposed
Max Amalgamation or the Adjournment Proposal related thereto.
Thus, these Shares will be counted for purposes of determining
whether a quorum is present. Brokers and nominees may vote such
Shares with respect to the Adjournment Proposal but may not vote
such Shares with respect to the Proposals related to the
Proposed Max Amalgamation.
Any Company shareholder giving a proxy may revoke it before its
exercise by providing the Companys Secretary with written
notice of revocation, by voting in person at the Companys
Annual General Meeting or by executing a later-dated proxy;
provided, however, that the action is taken in
sufficient time to permit the necessary examination and
tabulation of the subsequent proxy or revocation before the vote
is taken.
Abstentions and broker non-votes will be counted
toward the presence of a quorum at, but will not be considered
votes cast on any proposal brought before, the Company meeting.
Because the vote required to approve the proposals is the
affirmative vote of a majority of the votes cast, assuming a
quorum is present, a broker non-vote
-39-
with respect to any proposal to be voted on at the shareholder
meeting will not have the effect of a vote for or against the
relevant proposal, but will reduce the number of votes cast
needed to approve a proposal and therefore increase the relative
influence of those shareholders voting.
A vote by a show of hands will be taken in the first instance on
all matters (other than the election of directors) properly
brought before the Annual General Meeting unless a poll is
requested in accordance with the Company bye-laws. On a vote by
show of hands, every Company shareholder present in person and
every person holding a valid proxy will be entitled to one vote,
regardless of the number of shares owned or represented by that
person. If a poll is requested, subject to the voting
restrictions set out in the Companys bye-laws, each
shareholder present who elects to vote in person and each person
holding a valid proxy is entitled to one vote for each share
owned or represented. Votes for the election of directors may be
cumulated, as described below.
The Shares currently vote cumulatively in the election of
directors, which means that each shareholder, including a
shareholder holding Controlled Shares (as defined in the
Companys bye-laws), is entitled to the number of votes
that equals the number of votes that such shareholder would be
entitled to cast for the election of directors with respect to
its Shares multiplied by the number of persons standing for
election as director, and all votes entitled to be cast may be
cast for one or more of the directors being elected. If the
proposal described above regarding an amendment to the
Companys bye-laws to remove cumulative voting is adopted
by shareholders, the election of directors in any general
meeting of shareholders after the closing date will be subject
to the affirmative vote of a majority of the votes cast at the
general meeting (without cumulative voting).
Shareholders may (but need not) indicate the distribution of
their votes among the nominees in the space provided on the IPC
proxy card. Unless otherwise indicated on the proxy card, the
IPC proxies will cumulate votes represented by such proxy in
their discretion, except to the extent that authority so to
cumulate votes is expressly withheld as to any one or more of
the nominees.
The Companys shareholders (i) may vote
AGAINST any or all of the proposals, other than
Proposal #9 in respect of which it may
WITHHOLD, (ii) may abstain from voting on any
or all of the proposals, other than Proposal #9 in respect
of which it may WITHHOLD or (iii) may vote for
any or all of the proposals by marking the proper box on the
GOLD proxy card and signing, dating and returning it promptly in
the enclosed postage-paid envelope. If a Company shareholder
returns a GOLD proxy card that is signed, dated and not marked
with respect to a Proposal, that shareholder will be deemed to
have voted AGAINST Proposals #1 through #5
(IPC bye-law amendments), Proposal #6 (authorized share
capital increase), Proposal #7 (name change),
Proposal #8 (Authorization of Share Issuance) and
Proposal #10 (director compensation plan) and the
Adjournment Proposal as these Proposals are related to the Max
Amalgamation which we oppose.
If a Company shareholder returns a GOLD proxy card that is
signed and dated but not marked with respect to Proposal #9
(election of directors) or Proposal #11 (appointment of
KPMG), we will vote to WITHHOLD with respect to each
of the nominees listed in Proposal #9 and to
ABSTAIN with respect to Proposal #11. Also, if
no instructions as to cumulation of votes are given, your votes
will not be cumulated and your shares will be voted for each of
the nominees as directed.
Only the Companys shareholders (or their duly appointed
proxies) of record on the Record Date are eligible to vote in
person or submit a proxy.
YOU MAY REVOKE YOUR PROXY AT ANY TIME PRIOR TO ITS EXERCISE BY
ATTENDING THE ANNUAL GENERAL MEETING AND VOTING IN PERSON, BY
SUBMITTING A DULY EXECUTED, LATER DATED PROXY BY ONE OF THE
METHODS PROVIDED ON YOUR PROXY CARD OR BY SUBMITTING A WRITTEN
NOTICE OF REVOCATION TO EITHER (A) VALIDUS, CARE OF
GEORGESON INC., 199 WATER STREET, 26TH FLOOR, NEW YORK, NEW YORK
10038, OR (B) THE PRINCIPAL EXECUTIVE OFFICES OF THE
COMPANY AT AMERICAN INTERNATIONAL BUILDING, 29 RICHMOND ROAD,
PEMBROKE HM 08, BERMUDA. A REVOCATION MAY BE IN ANY WRITTEN
FORM VALIDLY SIGNED BY THE RECORD HOLDER AS LONG AS IT
CLEARLY STATES THAT THE PROXY PREVIOUSLY GIVEN IS NO LONGER
EFFECTIVE. SHAREHOLDERS WHO HOLD THEIR SHARES IN A BANK OR
BROKERAGE ACCOUNT WILL NEED TO NOTIFY THE PERSON RESPONSIBLE FOR
THEIR ACCOUNT TO REVOKE OR WITHDRAW PREVIOUSLY GIVEN
INSTRUCTIONS. WE REQUEST THAT
-40-
A COPY OF ANY REVOCATION SENT TO THE COMPANY OR ANY REVOCATION
NOTIFICATION SENT TO THE PERSON RESPONSIBLE FOR A BANK OR
BROKERAGE ACCOUNT ALSO BE SENT TO VALIDUS, CARE OF GEORGESON
INC., AT THE ADDRESS BELOW SO THAT VALIDUS MAY MORE ACCURATELY
DETERMINE IF AND WHEN PROXIES HAVE BEEN RECEIVED FROM THE
HOLDERS OF RECORD ON THE RECORD DATE OF A MAJORITY OF THE
COMPANYS SHARES THEN OUTSTANDING. UNLESS REVOKED IN THE
MANNER SET FORTH ABOVE, SUBJECT TO THE FOREGOING, DULY EXECUTED
PROXIES IN THE FORM ENCLOSED WILL BE VOTED AT THE ANNUAL
GENERAL MEETING AS SET FORTH ABOVE.
BY EXECUTING THE GOLD CARD YOU ARE AUTHORIZING THE PERSONS NAMED
AS PROXIES TO REVOKE ALL PRIOR PROXIES ON YOUR BEHALF.
If you have any questions or require any assistance in voting
your Shares, please contact:
199 Water Street
26th Floor
New York, New York 10038
Banks and Brokers should call:
(212) 440-9800
or
Toll Free at
(888) 274-5119
Email: validusIPC@georgeson.com
DISSENTERS
RIGHTS
The Companys shareholders are not entitled to
dissenters appraisal rights in connection with the
Proposed Max Amalgamation.
SOLICITATION
OF PROXIES
Except as set forth below, Validus will not pay any fees or
commissions to any broker, dealer, commercial bank, trust
company or other nominee for the solicitation of proxies in
connection with this solicitation.
Proxies will be solicited by mail, telephone, facsimile,
telegraph, the internet,
e-mail,
newspapers and other publications of general distribution and in
person. Directors and the officers of Validus and Validus Ltd.
listed on Schedule I hereto may assist in the solicitation
of proxies without any additional remuneration (except as
otherwise set forth in this Proxy Statement).
Validus has retained Georgeson Inc. (Georgeson) for
solicitation and advisory services in connection with
solicitations relating to the Annual General Meeting, for which
Georgeson may receive a fee of up to $250,000 in connection with
the solicitation of proxies for the Annual General Meeting. Up
to 50 people may be employed by Georgeson in connection
with the solicitation of proxies for the Annual General Meeting.
Validus has also agreed to reimburse Georgeson for out-of-pocket
expenses and to indemnify Georgeson against certain liabilities
and expenses, including reasonable legal fees and related
charges. Georgeson will solicit proxies for the Annual General
Meeting from individuals, brokers, banks, bank nominees and
other institutional holders. Directors, officers and certain
employees of Validus and Validus Ltd. may assist in the
solicitation of proxies without any additional remuneration. The
entire expense of soliciting proxies for the Annual General
Meeting by or on behalf of Validus is being borne by Validus.
If you have any questions concerning this Proxy Statement or the
procedures to be followed to execute and deliver a proxy, please
contact Georgeson at the address or phone number specified above.
-41-
FORWARD-LOOKING
STATEMENTS
This Proxy Statement may include forward-looking statements,
both with respect to us and our industry, that reflect our
current views with respect to future events and financial
performance. Statements that include the words
expect, intend, plan,
believe, project,
anticipate, will, may and
similar statements of a future or forward-looking nature
identify forward-looking statements. All forward-looking
statements address matters that involve risks and uncertainties.
Accordingly, there are or will be important factors that could
cause actual results to differ materially from those indicated
in such statements and, therefore, you should not place undue
reliance on any such statements. We believe that these factors
include, but are not limited to, the following:
1) uncertainty as to whether IPC will enter into and
consummate the proposed amalgamation on the terms set forth in
our offer letter; 2) unpredictability and severity of
catastrophic events; 3) rating agency actions;
4) adequacy of our risk management and loss limitation
methods; 5) cyclicality of demand and pricing in the
insurance and reinsurance markets; 6) our limited operating
history; 7) our ability to successfully implement our
business strategy during soft as well as
hard markets; 8) adequacy of our loss reserves;
9) continued availability of capital and financing;
10) retention of key personnel; 11) competition;
12) potential loss of business from one or more major
insurance or reinsurance brokers; 13) our ability to
implement, successfully and on a timely basis, complex
infrastructure, distribution capabilities, systems, procedures
and internal controls, and to develop accurate actuarial data to
support the business and regulatory and reporting requirements;
14) general economic and market conditions (including
inflation, volatility in the credit and capital markets,
interest rates and foreign currency exchange rates);
15) the integration of Talbot or other businesses we may
acquire or new business ventures we may start; 16) the
effect on our investment portfolio of changing financial market
conditions including inflation, interest rates, liquidity and
other factors; 17) acts of terrorism or outbreak of war;
and 18) availability of reinsurance and retrocessional
coverage, as well as managements response to any of the
aforementioned factors.
The foregoing review of important factors should not be
construed as exhaustive and should be read in conjunction with
the other cautionary statements that are included herein and
elsewhere, including the Risk Factors included in our most
recent reports on
Form 10-K
and
Form 10-Q
and other documents on file with the SEC. Any forward-looking
statements made in this Proxy Statement are qualified by these
cautionary statements, and there can be no assurance that the
actual results or developments anticipated by us will be
realized or, even if substantially realized, that they will have
the expected consequences to, or effects on, us or our business
or operations. We undertake no obligation to update publicly or
revise any forward-looking statement, whether as a result of new
information, future developments or otherwise.
OTHER
INFORMATION
The information concerning the Company and the Proposed Max
Amalgamation contained herein has been taken from, or is based
upon, publicly available documents on file with the SEC and
other publicly available information. Although Validus has no
knowledge that would indicate that statements relating to the
Company or the Max Amalgamation Agreement contained in this
Proxy Statement, in reliance upon publicly available
information, are inaccurate or incomplete, to date it has not
had access to the full books and records of the Company, was not
involved in the preparation of such information and statements
and is not in a position to verify any such information or
statements.
Pursuant to
Rule 14a-5
promulgated under the Securities Exchange Act of 1934, as
amended (the Exchange Act), reference is made to the
joint proxy statement/prospectus included in the IPC/Max
S-4 for
information concerning the Max Amalgamation Agreement, the
Proposed Max Amalgamation, financial information regarding Max,
the Company and the proposed combination of Max and the Company,
the proposals to be voted upon at the Annual General Meeting,
the Shares, the beneficial ownership of Shares by the principal
holders thereof, other information concerning the Companys
management, the procedures for submitting proposals for
consideration at the next annual meeting of shareholders of the
Company and certain other matters regarding the Company and the
Annual General Meeting. See Schedule II for information
regarding persons who beneficially own more than 5% of the
Shares and the ownership of the Shares by the management of IPC
Holdings, Ltd.
WE URGE YOU NOT TO RETURN ANY PROXY CARD YOU RECEIVE FROM THE
COMPANY. EVEN IF YOU PREVIOUSLY HAVE SUBMITTED A PROXY CARD
FURNISHED BY THE COMPANY, IT IS NOT
-42-
TOO LATE TO CHANGE YOUR VOTE BY SIMPLY SIGNING, DATING AND
RETURNING THE ENCLOSED GOLD PROXY CARD TODAY. THEREFORE, WE URGE
YOU TO SIGN, DATE AND RETURN THE ENCLOSED GOLD PROXY CARD TO US.
WHETHER OR NOT YOU INTEND TO ATTEND THE ANNUAL GENERAL MEETING,
YOUR PROMPT ACTION IS IMPORTANT. MAKE YOUR VIEWS CLEAR TO THE
COMPANYS BOARD BY VOTING AGAINST
PROPOSALS #1 THROUGH #8 AND #10 AND ANY
ADJOURNMENT PROPOSAL AND SIGNING, DATING AND RETURNING THE
ENCLOSED GOLD PROXY CARD TODAY.
IF A COMPANY SHAREHOLDER RETURNS A GOLD PROXY CARD THAT IS
SIGNED, DATED AND NOT MARKED WITH RESPECT TO A PROPOSAL, THAT
SHAREHOLDER WILL BE DEEMED TO HAVE VOTED AGAINST
PROPOSALS #1 THROUGH #5 (IPC BYE-LAW AMENDMENTS),
PROPOSAL #6 (AUTHORIZED SHARE CAPITAL INCREASE),
PROPOSAL #7 (NAME CHANGE), PROPOSAL #8 (AUTHORIZATION
OF SHARE ISSUANCE) AND PROPOSAL #10 (DIRECTOR COMPENSATION
PLAN) AND THE ADJOURNMENT PROPOSAL AS THESE
PROPOSALS ARE RELATED TO THE MAX AMALGAMATION WHICH WE
OPPOSE.
IF A COMPANY SHAREHOLDER RETURNS A GOLD PROXY CARD THAT IS
SIGNED AND DATED BUT NOT MARKED WITH RESPECT TO PROPOSAL #9
(ELECTION OF DIRECTORS) OR PROPOSAL #11 (APPOINTMENT OF
KPMG), WE WILL VOTE TO WITHHOLD WITH RESPECT TO EACH
OF THE NOMINEES LISTED IN PROPOSAL #9 AND TO
ABSTAIN WITH RESPECT TO PROPOSAL #11.
YOUR VOTE IS IMPORTANT, NO MATTER HOW MANY OR HOW FEW SHARES YOU
OWN.
VALIDUS HOLDINGS, LTD.
April 20, 2009
-43-
IMPORTANT
VOTING INFORMATION
1. If your Shares are held in your own name, please sign,
date and return the enclosed GOLD proxy card to Validus
Holdings, Ltd., care of Georgeson Inc., in the postage-paid
envelope provided.
2. If your Shares are held in street-name, only
your broker or bank can vote your Shares and only upon receipt
of your specific instructions. If your Shares are held in
street-name, deliver the enclosed GOLD proxy card to
your broker or bank or contact the person responsible for your
account to vote on your behalf and to ensure that a GOLD proxy
card is submitted on your behalf. We urge you to confirm in
writing your instructions to the person responsible for your
account and to provide a copy of those instructions to Validus
Holdings, Ltd., care of Georgeson Inc., 199 Water Street,
26th Floor, New York, New York 10038, at
(888) 274-5119,
so that Validus will be aware of all instructions given and can
attempt to ensure that such instructions are followed.
3. Do not sign or return any
[ ] proxy card you may receive
from the Company. If you have already submitted a
[ ] proxy card, it is not too
late to change your vote simply sign, date and
return the GOLD proxy card. Only your latest dated proxy will be
counted.
4. Only the Companys shareholders of record
on ,
2009 are entitled to vote at the Annual General Meeting. We urge
each shareholder to ensure that the holder of record of his or
her Share(s) signs, dates, and returns the enclosed GOLD proxy
card as soon as possible.
If you have any questions or require any assistance in voting
your Shares, please contact:
199 Water Street
26th Floor
New York, New York 10038
Banks and Brokers should call:
(212) 440-9800
or
Toll Free at
(888) 274-5119
Email: validusIPC@georgeson.com
THE VALIDUS OFFER DESCRIBED IN THIS PROXY STATEMENT MAY BECOME
THE SUBJECT OF A REGISTRATION STATEMENT ON
FORM S-4
FILED WITH THE SEC. INVESTORS AND SECURITY HOLDERS ARE ADVISED
TO READ SUCH REGISTRATION STATEMENT, ALL OTHER APPLICABLE
DOCUMENTS AND ANY AMENDMENTS OR SUPPLEMENTS THERETO IF AND WHEN
THEY BECOME AVAILABLE BECAUSE EACH WILL CONTAIN IMPORTANT
INFORMATION. INVESTORS AND SECURITY HOLDERS MAY OBTAIN A FREE
COPY OF ANY DOCUMENTS FILED BY VALIDUS WITH THE SEC AT THE
SECS WEBSITE (www.sec.gov) OR BY DIRECTING SUCH REQUESTS
TO GEORGESON INC., 199 WATER STREET, 26TH FLOOR, NEW YORK, NEW
YORK 10038, AT
(888) 274-5119
OR BY EMAIL AT validusIPC@georgeson.com.
-44-
SCHEDULE I
INFORMATION
CONCERNING DIRECTORS, OFFICERS AND
OTHER PARTICIPANTS OF VALIDUS AND VALIDUS LTD.
|
|
1.
|
Directors
and Participant Executive Officers of Validus.
|
The following table sets forth certain information with respect
to each director and Participant executive officer of Validus
that is a Participant in the solicitation. Unless otherwise
indicated, the current business address of each person is
19 Par-La-Ville Road Hamilton HM11 Bermuda and the current
business telephone number is
(441) 278-9000.
Unless otherwise indicated, each such person is a citizen of the
United States, and each occupation set forth opposite an
individuals name refers to employment with Validus.
DIRECTORS
|
|
|
|
|
Present Principal Occupation or Employment, Material
Positions
|
Name and Current Business Address
|
|
Held During the Past Five Years and Business Address Thereof,
Citizenship
|
|
Edward J. Noonan
|
|
Mr. Noonan has been Chairman of the Board and the Chief
Executive Officer of Validus since its formation. He has
27 years of experience in the insurance and reinsurance
industry, serving most recently as the acting chief executive
officer of United America Indemnity Ltd. (Nasdaq: INDM) from
February 2005 through October 2005 and as a member of the board
of directors from December 2003 to May 2007. Mr. Noonan
served as president and chief executive officer of American
Re-Insurance Company from 1997 to 2002, having joined American
Re in 1983. Mr. Noonan also served as chairman of
Inter-Ocean Reinsurance Holdings of Hamilton, Bermuda from 1997
to 2002. Prior to joining American Re, Mr. Noonan worked at
Swiss Reinsurance from 1979 to 1983.
|
Matthew J. Grayson
|
|
Mr. Grayson has been a Director of Validus since its
formation. He also serves as a senior principal of Aquiline.
Mr. Grayson has 24 years experience in the financial
services industry. In 1998, following a career in investment
banking, corporate finance and capital markets, Mr. Grayson
co-founded Venturion Capital, a private equity firm that
specialized in global financial services companies. In 2005,
Venturion Capitals professionals joined with Jeffrey W.
Greenberg, along with others, to form Aquiline.
Mr. Grayson serves on the board of Structured Credit
Holdings Plc and has served as Director of Tygris Commercial
Finance Group since May of 2008. In 2007, Structured Credit
Holdings successfully completed a scheme of arrangement in the
Irish High Court with its creditors.
|
Jeffrey W. Greenberg
|
|
Mr. Greenberg has been a Director of Validus since its
formation. He also serves as the managing principal of Aquiline,
which he founded in 2005. Mr. Greenberg served as chairman
and chief executive officer of Marsh & McLennan
Companies, Inc. from 2000 to 2004. From 1996 to 2004,
Mr. Greenberg was the chairman of MMC Capital, the manager
of the Trident Funds. He previously served as a director of Ace,
Inc. Previously, he served as a senior executive of AIG, where
he was employed from 1978 to 1995. Mr. Greenberg is also
Chairman of Group Ark Insurance Holdings Ltd., a Bermuda-based
underwriter of insurance and reinsurance risks in the
Lloyds market.
|
I-1
|
|
|
|
|
Present Principal Occupation or Employment, Material
Positions
|
Name and Current Business Address
|
|
Held During the Past Five Years and Business Address Thereof,
Citizenship
|
|
John J. Hendrickson
|
|
Mr. Hendrickson has been a Director of Validus since its
formation. He is also the Founder and Managing Partner of SFRi
LLC, an independent investment and advisory firm (formed in
2004) specializing in the insurance industry. From 1995 to
2004, Mr. Hendrickson held various positions with Swiss Re,
including as Member of the Executive Board, Head of Capital
Partners (Swiss Res Merchant Banking Division),
Co-Founding Partner of Securities Capital, a private equity
firm, and Managing Director of Fox-Pitt Kelton, Swiss Res
Investment Banking Subsidiary. From 1985 to 1995,
Mr. Hendrickson was with Smith Barney, the U.S. investment
banking firm, where he focused on serving the capital and
strategic needs of (re)insurance clients and private equity
investors active in the insurance sector. Mr. Hendrickson
has served as a director for several insurance and financial
services companies, and, in addition to Validus, currently
serves on the board of CX Reinsurance Company Limited and Tawa
PLC.
|
Sander M. Levy
|
|
Mr. Levy has been a Director of Validus since its
formation. He also serves as a Managing Director of Vestar
Capital Partners, a private equity investment firm based in New
York which manages over $7 billion of equity capital, and
was a founding partner of Vestar Capital Partners at its
inception in 1988. Mr. Levy is currently a member of the
board of directors of Symetra Financial Corporation, Wilton Re
Holdings Limited and Duff & Phelps, LLC.
|
Jean-Marie Nessi
|
|
Mr. Nessi has been a Director of Validus since its
formation. He has also served as a director of Matmut
Enterprises since 2007. Mr. Nessi also has served as the
head of Aon Global Risk Consulting at Aon France since October
2007. Mr. Nessi served as Chairman and CEO of NessPa
Holding from January 2006 to September 2007 and as the head of
the property and casualty business unit for PartnerRe Global, a
subsidiary of PartnerRe SA, from 2003 to January 2006. He was
appointed Chairman of PartnerRe SA in June of 2003. Prior to
PartnerRe, Mr. Nessi led AXA Corporate Solutions, the
successor company to AXA Ré and AXA Global Risk.
Mr. Nessi is a citizen of France.
|
Mandakini Puri
|
|
Ms. Puri has been a Director of Validus since its
formation. She also serves as a Senior Vice President with
Merrill Lynch Global Private Equity, where she is the Chief
Investment Officer. Ms. Puri has been part of Merrill
Lynchs private equity business since 1994, prior to which
she was a Director in the High Yield Finance &
Restructuring Group at Merrill. Ms. Puri joined Merrill
Lynch in 1986. Mr. Puri is a member of the board of
directors of PSi Technologies Holdings, Inc.
|
Sumit Rajpal
|
|
Mr. Rajpal has been a director of Validus since November
2008. He is also a managing director of Goldman,
Sachs & Co. He joined Goldman, Sachs & Co.
in 2000 and became a managing director in 2007. Mr. Rajpal
also serves as a director on the boards of HealthMarkets, Inc.,
USI Holdings Corporation, CSI Entertainment, Alliance Films
Holdings Inc., CW Media Holdings, Inc. and Dollar General
Corporation (where he is an observer on the board).
|
George P. Reeth
|
|
Mr. Reeth has been President and Deputy Chairman of Validus
since its formation and has senior operating and distribution
responsibilities. Mr. Reeth, who has 30 years
experience in the insurance and reinsurance industry, was a
senior executive with Willis Group Limited from 1992 to 2005 and
was chairman & chief executive officer of North
American Reinsurance Operations for Willis Re Inc. from 2000 to
2005. Prior to Willis, Mr. Reeth was executive vice
president at Wilcox, Inc. Prior to Wilcox, Mr. Reeth was a
senior professional with E.W. Payne Intermediaries from 1986 to
1988 and with Intere Intermediaries, Inc.
|
I-2
|
|
|
|
|
Present Principal Occupation or Employment, Material
Positions
|
Name and Current Business Address
|
|
Held During the Past Five Years and Business Address Thereof,
Citizenship
|
|
Alok Singh
|
|
Mr. Singh has been a Director of Validus since its
formation. He also serves as a Managing Director of New Mountain
Capital, a private equity investment firm based in New York
which manages over $7 billion of equity capital. Prior to
joining New Mountain Capital in 2002, Mr. Singh served as a
Partner and Managing Director of Bankers Trust from 1978 to
2001. In 2001 he established the Corporate Financial Advisory
Group for the Americas for Barclays Capital, and led the group
until 2002. Mr. Singh is non-executive chairman of Overland
Solutions, Inc. and a director of Apptis, Inc., Deltek, Inc, and
Ikaria Holdings, Inc.
|
Christopher E. Watson
|
|
Mr. Watson has been a Director of Validus since its
formation. He also serves as a senior principal of Aquiline,
which he joined in 2006. Mr. Watson has more than
33 years of experience in the financial services industry.
From 1987 to 2004, Mr. Watson served in a variety of
executive roles within the property & casualty
insurance businesses of Citigroup and its predecessor entities.
From 1995 to 2004, Mr. Watson was president and chief
executive officer of Gulf Insurance Group, one of the largest
surplus lines insurance companies in the world. Mr. Watson
served as a senior executive of AIG from 1974 to 1987.
Mr. Watson is also a director of Group Ark Insurance
Holdings Ltd., a Bermuda-based underwriter of insurance and
reinsurance risks in the Lloyds market.
|
PARTICIPANT
EXECUTIVE OFFICERS
|
|
|
|
|
Present Principal Occupation or Employment, Material
Positions
|
Name and Current Business Address
|
|
Held During the Past Five Years and Business Address Thereof,
Citizenship
|
|
Edward J. Noonan
|
|
Mr. Noonan has been Chairman of the Board and the Chief
Executive Officer of Validus since its formation. He has
27 years of experience in the insurance and reinsurance
industry, serving most recently as the acting chief executive
officer of United America Indemnity Ltd. (Nasdaq: INDM) from
February 2005 through October 2005 and as a member of the board
of directors from December 2003 to May 2007. Mr. Noonan
served as president and chief executive officer of American
Re-Insurance Company from 1997 to 2002, having joined American
Re in 1983. Mr. Noonan also served as chairman of
Inter-Ocean Reinsurance Holdings of Hamilton, Bermuda from 1997
to 2002. Prior to joining American Re, Mr. Noonan worked at
Swiss Reinsurance from 1979 to 1983.
|
Joseph E. (Jeff) Consolino
|
|
Mr. Consolino has been Executive Vice President and Chief
Financial Officer of Validus since March 2006. He has over
16 years of experience in the financial services industry,
specifically in providing investment banking services to the
insurance industry, and most recently served as a managing
director in Merrill Lynchs Financial Institutions Group
specializing in insurance company advisory and financing
transactions. He serves as a Director of National Interstate
Corporation, a property and casualty company based in Ohio and
of AmWINS Group, Inc., a wholesale insurance broker based in
North Carolina.
|
I-3
|
|
2.
|
Directors
and Participant Executive Officers of Validus Ltd.
|
The following table sets forth certain information with respect
to each director and each Participant executive officer of
Validus Ltd. Unless otherwise indicated, the current business
address of each person is 19 Par-La-Ville Road Hamilton
HM11 Bermuda and the current business telephone number is
(441) 278-9000.
Unless otherwise indicated, each such person is a citizen of the
United States.
DIRECTORS
|
|
|
|
|
Present Principal Occupation or Employment, Material
Positions
|
Name and Current Business Address
|
|
Held During the Past Five Years and Business Address Thereof,
Citizenship
|
|
Stuart W. Mercer
|
|
Mr. Mercer has been a director of Validus Ltd. since its
formation. Mr. Mercers principal occupation is
executive vice president and chief risk officer of Validus.
Mr. Mercer has over 18 years of experience in the
financial industry focusing on structured derivatives, energy
finance and reinsurance. Previously, Mr. Mercer was a
senior advisor to DTE Energy Trading.
|
C. Jerome Dill
|
|
Mr. Dill has been a director of Validus Ltd. since its
formation. Mr. Dills principal occupation is
executive vice president and general counsel of Validus. Prior
to joining Validus, Mr. Dill was a partner with the law
firm of Appleby Hunter Bailhache, which he joined in 1986.
Mr. Dill serves on the Board of Directors of Bermuda
Commercial Bank.
|
Conan M. Ward
|
|
Mr. Ward has been a director of Validus Ltd. since its
formation. Mr. Wards principal occupation is
executive vice president and chief underwriting officer of
Validus. Mr. Ward has over 16 years of insurance
industry experience. Mr. Ward was executive vice president
of the Global Reinsurance division of Axis Capital Holdings,
Ltd. from November 2001 until November 2005, where he oversaw
the divisions worldwide property catastrophe, property per
risk, property pro rata portfolios. He is one of the founders of
Axis Specialty, Ltd and was a member of the Operating Board and
Senior Management Committee of Axis Capital. From July 2000 to
November 2001, Mr. Ward was a senior vice president at Guy
Carpenter & Co.
|
PARTICIPANT
EXECUTIVE OFFICERS
|
|
|
|
|
Present Principal Occupation or Employment, Material
Positions
|
Name and Current Business Address
|
|
Held During the Past Five Years and Business Address Thereof,
Citizenship
|
|
Edward J. Noonan
|
|
Mr. Noonan has been Chief Executive Officer of Validus Ltd.
since its formation. Mr. Noonans principal occupation is
chief executive officer and chairman of Validus. For
biographical information, see 1. Directors and
Participant Executive Officers of Validus above.
|
Joseph E. (Jeff) Consolino
|
|
Mr. Consolino has been Chief Financial Officer and
Executive Vice President of Validus Ltd. since its formation.
Mr. Consolinos principal occupation is executive vice
president and chief financial officer of Validus. For
biographical information, see 1. Directors and
Participant Executive Officers of Validus above.
|
I-4
SCHEDULE II
THE
FOLLOWING TABLE IS REPRINTED FROM THE COMPANYS
REGISTRATION
STATEMENT ON
FORM S-4
FILED WITH THE SECURITIES AND
EXCHANGE COMMISSION ON MARCH 27, 2009.
SECURITY
OWNERSHIP OF PRINCIPAL SHAREHOLDERS AND MANAGEMENT
The table below sets forth certain information as of
March 26, 2009, (unless otherwise specified) with respect
to the beneficial ownership of Company common shares by each
person who is known to Company, based on filings made by such
person under Section 13(d) and Section 13(g) of the
Exchange Act, to own beneficially more than 5% of the
outstanding common shares, each person currently serving as a
director of Company, each nominee for director, the Chief
Executive Officer, the Chief Financial Officer, each of the two
most highly compensated executive officers of the Company other
than the Chief Executive Officer and Chief Financial Officer and
all directors and executive officers as a group.
|
|
|
|
|
|
|
|
|
|
|
Amount and Nature
|
|
|
|
|
|
|
of Beneficial
|
|
|
|
|
Name and Address of Beneficial Owner
|
|
Ownership(1)
|
|
|
Percentage(2)
|
|
|
FMR LLC
82 Devonshire Street
Boston, Massachusetts 02109
|
|
|
4,965,479
|
(3)
|
|
|
8.9
|
%
|
Franklin Resources, Inc.
One Franklin Parkway
San Mateo, California
94403-1906
|
|
|
3,926,292
|
(4)
|
|
|
7.0
|
%
|
Barclays Global Investors, NA.
400 Howard Street
San Francisco, California 94105
|
|
|
2,811,789
|
(5)
|
|
|
5.0
|
%
|
Mark R. Bridges
|
|
|
891
|
(6)
|
|
|
|
*
|
James P. Bryce
|
|
|
324,524
|
(7)
|
|
|
|
*
|
Michael J. Cascio
|
|
|
155
|
(6)
|
|
|
|
*
|
Peter S. Christie
|
|
|
891
|
(6)
|
|
|
|
*
|
Kenneth L. Hammond
|
|
|
891
|
(6)
|
|
|
|
*
|
L. Anthony Joaquin
|
|
|
891
|
(6)
|
|
|
|
*
|
Antony P.D. Lancaster
|
|
|
891
|
(6)
|
|
|
|
*
|
Peter J.A. Cozens
|
|
|
140,340
|
(8)
|
|
|
|
*
|
Stephen F. Fallon
|
|
|
144,669
|
(9)
|
|
|
|
*
|
John R. Weale
|
|
|
161,047
|
(10)
|
|
|
|
*
|
All directors and executive officers as a group
|
|
|
775,190
|
|
|
|
1.4
|
%
|
|
|
|
* |
|
Less than 1% of the outstanding common shares. |
|
(1) |
|
In accordance with the rules of the SEC, a person is deemed to
have beneficial ownership of common shares that such
person has the rights to acquire within 60 days. For
purposes of calculating percent ownership, each persons
holdings have been calculated assuming full exercise of
outstanding options currently exercisable or exercisable within
60 days by such person and by including such persons
restricted stock units and performance share units vesting
within 60 days, but not the exercise of options held by any
other person. All amounts listed represent sole investment and
voting power unless otherwise indicated. |
|
(2) |
|
Based on 55,948,821 common shares issued and outstanding at
March 26, 2009. |
|
(3) |
|
According to information in the Schedule 13G/A filed on
February 17, 2009, FMR LLC had the following dispositive
powers with respect to common shares: (a) sole voting
power: none; (b) shared voting power: none; (c) sole
dispositive power: 4,965,479; and (d) shared dispositive
power: none. |
II-1
|
|
|
(4) |
|
According to information reported in the Schedule 13G/A
filed on February 6, 2009, Franklin Resources, Inc. had the
following dispositive powers with respect to common shares:
(a) sole voting power: 3,862,492; (b) shared voting
power: none; (c) sole dispositive power: 3,926,292;
(d) shared dispositive power: none. |
|
(5) |
|
According to information reported in the Schedule 13G filed
on February 5, 2009, Barclays Global Investors, NA. had the
following dispositive powers with respect to common shares:
(a) sole voting power: 2,540,495; (b) shared voting
power: none; (c) sole dispositive power: 2,811,789;
(d) shared dispositive power: none. |
|
(6) |
|
Transfer-restricted common shares awarded as compensation for
his services as a Director. |
|
(7) |
|
Includes 581 common shares that are held by the IRA trustee for
Mr. Bryces wife, for which Mr. Bryce disclaims
beneficial ownership, 175,000 common shares issuable upon the
exercise of options and 7,429 transfer-restricted common shares. |
|
(8) |
|
Includes 81,250 common shares issuable upon the exercise of
options and 2,928 transfer-restricted common shares. |
|
(9) |
|
Includes 78,750 common shares issuable upon the exercise of
options and 2,556 transfer-restricted common shares. |
|
|
|
(10) |
|
Includes 115,750 common shares issuable upon the exercise of
options and 2,637 transfer-restricted common shares. |
II-2
IMPORTANT
If your Shares are held in your own name, please sign, date and
return the enclosed GOLD proxy card today. If your shares are
held in Street-Name, only your broker or bank can
vote your shares and only upon receipt of your specific
instructions. Please return the enclosed GOLD proxy card to your
broker or bank and contact the person responsible for your
account to ensure that a GOLD proxy card is voted on your behalf.
We urge you not to sign any proxy card you may receive from the
Company, even in protest.
If you have any questions or require any assistance in voting
your Shares, please contact:
199 Water Street
26th Floor
New York, New York 10038
Banks and Brokers should call:
(212) 440-9800
or
Toll Free at
(888) 274-5119
Email: validusIPC@georgeson.com
[Preliminary
Copy Subject to Completion]
IMPORTANT:
PLEASE SIGN, DATE AND RETURN THIS PROXY CARD
IN THE ENCLOSED ENVELOPE
SOLICITATION
BY VALIDUS HOLDINGS, LTD. AND VALIDUS LTD.
IN OPPOSITION TO THE SOLICITATION BY THE BOARD OF DIRECTORS
OF
IPC HOLDINGS, LTD. (IPC OR THE COMPANY).
The undersigned, a holder of Common Shares (the
Shares) of IPC Holdings, Ltd. acknowledges receipt
of the Proxy Statement of Validus Holdings, Ltd. and Validus
Ltd.
dated ,
2009, and the undersigned revokes all prior proxies delivered in
connection with the Annual General Meeting of Shareholders of
the Company (the Annual General Meeting) to issue
Shares and certain other related proposals in connection with
the Agreement and Plan of Amalgamation dated as of March 1,
2009, as amended by Amendment No. 1 to the Agreement and
Plan of Amalgamation dated as of March 5, 2009, among Max
Capital Group Ltd., the Company and IPC Limited and
appoints ,
and
and/or each
of them, with full power of substitution, proxies for the
undersigned to vote all Shares which the undersigned would be
entitled to vote at the Annual General Meeting and any
adjournments, postponements or reschedulings thereof, and
instructs said proxies to vote as follows:
EXCEPT AS PROVIDED HEREIN, THIS PROXY WILL BE VOTED IN
ACCORDANCE WITH THE SPECIFICATIONS MADE. IF NO SPECIFICATIONS
ARE MADE AND YOU HAVE SIGNED THIS PROXY CARD, THIS PROXY WILL BE
VOTED (i) AGAINST EACH OF PROPOSALS #1
THROUGH #8, #10 AND #12, (ii) TO WITHHOLD
FOR EACH OF THE NOMINEES LISTED IN PROPOSAL #9,
(iii) TO ABSTAIN WITH RESPECT TO PROPOSAL #11 AND
(iv) IN THE DISCRETION OF THE NAMED PROXIES ON ANY OTHER
MATTER THAT MAY BE PRESENTED AT THE ANNUAL GENERAL MEETING.
THIS PROXY WILL REVOKE (OR BE USED BY THE PROXIES TO REVOKE)
ANY PRIOR PROXY DELIVERED IN CONNECTION WITH THE
PROPOSALS LISTED BELOW TO THE EXTENT IT IS VOTED AT THE
ANNUAL GENERAL MEETING AS STIPULATED ABOVE.
BY EXECUTING THE GOLD CARD YOU ARE AUTHORIZING THE PERSONS NAMED
AS PROXIES TO REVOKE ALL PRIOR PROXIES ON YOUR BEHALF.
(continued
and to be signed and dated on reverse)
VALIDUS
HOLDINGS, LTD.
VALIDUS LTD.
PROXY VOTING INSTRUCTIONS
Your vote is important. Casting your vote in one of the three
ways described on this proxy card votes all Common Shares of IPC
Holdings, Ltd. that you are entitled to vote.
|
|
|
Please mark your votes with an x as
shown in this example.
Please do not write outside the designated areas.
|
|
x
|
Annual General Meeting Proxy Card
A. Proposals
Validus strongly recommends a vote AGAINST each of Proposals
number #1 through #8, #10 and #12. Validus
makes no recommendation with respect to (i) each of the
nominees listed in Proposal #9 and
(ii) Proposal #11.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
Proposal 1.
|
|
To approve an amendment to IPCs bye-laws effective as of
the effective time of the amalgamation to increase the maximum
number of directors on IPCs board of directors from nine
to twelve, pursuant to the amalgamation agreement.
|
|
o
|
|
o
|
|
o
|
|
|
Proposal 2.
|
|
To approve an amendment to IPCs bye-laws effective as of
the effective time of the amalgamation to modify the indemnity
provisions, pursuant to the amalgamation agreement.
|
|
o
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
Proposal 3.
|
|
To approve an amendment to IPCs bye-laws effective as of
the effective time of the amalgamation to add provisions
regarding advance notice of shareholder nominees for director
and other shareholder proposals, pursuant to the amalgamation
agreement.
|
|
o
|
|
o
|
|
o
|
|
|
Proposal 4.
|
|
To approve an amendment to IPCs bye-laws effective as of
the effective time of the amalgamation to remove provisions for
alternate directors and to remove the provision permitting
cumulative voting in the election of directors, pursuant to the
amalgamation agreement.
|
|
o
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
Proposal 5.
|
|
To approve an amendment to IPCs bye-laws effective as of
the effective time of the amalgamation to add certain conditions
to the conduct of director meetings, pursuant to the
amalgamation agreement.
|
|
o
|
|
o
|
|
o
|
|
|
Proposal 6.
|
|
To approve effective as of the effective time of the
amalgamation the increase in IPCs authorized share capital
from $1,850,000 to $2,350,000 by the creation of an additional
50,000,000 common shares, par value $0.01 per share, ranking
pari passu with the existing common shares of IPC, pursuant to
the amalgamation agreement.
|
|
o
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
Proposal 7.
|
|
To approve effective as of the effective time of the
amalgamation the change in IPCs name to Max Capital
Group Ltd. pursuant to the amalgamation agreement.
|
|
o
|
|
o
|
|
o
|
|
|
Proposal 8.
|
|
To approve the issuance of shares of IPC pursuant to the
amalgamation agreement.
|
|
o
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposal 9.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A. To elect six directors of IPC to hold office from the
close of the IPC Annual General Meeting until the Companys
next annual general meeting of shareholders or until their
successors are elected or appointed or their office otherwise
vacated.
|
|
|
|
|
|
|
For
|
|
Withhold
|
|
|
|
|
|
|
|
|
|
For
|
|
Withhold
|
01
|
|
Kenneth L. Hammond
|
|
|
|
o
|
|
o
|
|
|
02
|
|
|
Mark R. Bridges
|
|
|
|
o
|
|
o
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03
|
|
Michael J. Cascio
|
|
|
|
o
|
|
o
|
|
|
04
|
|
|
Peter S. Christie
|
|
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
05
|
|
L. Anthony Joaquin
|
|
|
|
o
|
|
o
|
|
|
06
|
|
|
Antony P. D. Lancaster
|
|
|
|
o
|
|
o
|
|
B. To elect six of the 12 directors of the combined entity,
effective as of the effective time of the amalgamation, pursuant
to the amalgamation agreement.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Withhold
|
|
|
|
|
|
|
|
|
|
For
|
|
Withhold
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07
|
|
W. Marston Becker
|
|
|
|
o
|
|
o
|
|
|
08
|
|
|
Gordon F. Cheesbrough
|
|
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09
|
|
K. Bruce Connell
|
|
|
|
o
|
|
o
|
|
|
10
|
|
|
Willis T. King, Jr.
|
|
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11
|
|
Mario P. Torsiello
|
|
|
|
o
|
|
o
|
|
|
12
|
|
|
James L. Zech
|
|
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
To cumulate votes, place the number of votes for a director on
the line next to such directors name. If no instructions
as to cumulation of votes are given, your votes will not be
cumulated and your shares will be voted for each of the
nominees.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
Proposal 10.
|
|
To approve a revised plan of remuneration for IPCs board
of directors effective as of the effective time of the
amalgamation.
|
|
o
|
|
o
|
|
o
|
|
|
Proposal 11.
|
|
To appoint KPMG as IPCs independent auditors until the
close of the next annual general meeting and to authorize the
audit committee of IPCs board of directors to set the
compensation of such independent auditors.
|
|
o
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
|
|
|
|
|
|
|
|
|
|
Proposal 12.
|
|
To approve the adjournment of the IPC meeting for the
solicitation of additional proxies, if necessary, in favor of
any of the above proposals.
|
|
o
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
B. Authorized
Signatures This section must be completed for your
vote to be counted. Please sign and date below.
Please sign exactly as name(s) appears hereon. Joint owners
should each sign. When signing as attorney, executor,
administrator, corporate officer, trustee, guardian, or
custodian, please give full title. If a partnership, please sign
in partnership name by authorized person.
|
|
|
|
|
|
|
Date (mm/dd/yyyy) Please print date below.
|
|
|
Signature 1 Please keep signature within the box
|
|
|
Signature 2 Please keep signature within the box
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proxy Validus Holdings, Ltd. and Validus Ltd.
3